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1. INTRODUCTION 
1.1 Background 
A huge expansion within industry and technology has taken place in the 20th 
century, leading to development of numerous chemicals with properties favourable for 
specific purposes. Such chemicals are often present in consumer products we regularly 
come in contact with in everyday life. One large group of widely used chemicals is the 
per- and polyfluorinated compounds (PFCs). The PFCs consists of a carbon chain which 
is partly (poly) or fully (per) fluorinated and with different functional groups attached. 
The carbon chain can be either linear or branched. In Table 1 the PFCs studied in this 
thesis are listed together with the abbreviations. 
Depending on the functional group, PFCs may be divided in two classes: ionic and 
neutral PFCs. Ionic PFCs such as perfluoroalkyl sulfonates (PFSAs) and perfluoroalkyl 
carboxylates (PFCAs) possesses an acidic group which is dissociated around neutral pH. 
PFCAs and PFSAs are highly resistant to physical, chemical and microbial degradation 
(Kissa 2001). Neutral PFCs such as perfluoroalkyl sulfonamides (FOSAs), perfluoroalkyl 
sulfonamidoethanols (FOSEs) and fluorotelomer alcohols (FTOHs) have a polar, non-
ionic functional group. The chemical resistance, surface tension lowering properties and 
ability to create stable foams have made the PFCs extremely versatile, and they have been 
used in numerous consumer products and industrial processes such as in inks, varnishes, 
waxes, lubricants, hydraulic oils, fire fighting foams, food packaging, for metal plating 
and coating formulations, as water and oil repellents for leather, paper and textiles and as 
emulsifiers in fluoropolymer production (Kissa 2001;Prevedouros et al. 2006). 
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Table 1: List of PFCs studied in this thesis 
 Compound Abbreviation Group abbreviation  
Perfluorobutane sulfonate PFBS 
Perfluoropentane sulfonate PFPeS 
Perfluorohexane sulfonate PFHxS 
Perfluoroheptane sulfonate   PFHpS 
Perfluorooctane sulfonate PFOS 
Perfluorononane sulfonate PFNS 
Perfluorodecane sulfonate PFDS 
Perfluoroalkyl sulfonates 
(PFSAs) 
Perfluorobutanoate PFBA 
Perfluoropentanoate PFPeA 
Perfluorohexanoate PFHxA 
Perfluoroheptanoate PFHpA 
Perfluorooctanoate PFOA 
Perfluorononanoate PFNA 
Perfluorodecanoate PFDA 
Perfluoroundecanoate PFUnDA 
Perfluorododecanoate PFDoDA 
Perfluorotridecanoate PFTrDA 
Perfluorotetradecanoate PFTeDA 
Perfluoropentadecanoate PFPeDA 
Perfluorohexadecanoate PFHxDA 
Perfluorooctadecanoate PFODA 
Perfluoroalkyl carboxylates 
(PFCAs) 
Io
ni
c 
PF
C
s 
Perfluorooctane sulfonamide PFOSA 
N-Methylperfluorooctane 
sulfonamide  MeFOSA 
N-Ethylperfluorooctane sulfonamide EtFOSA 
Perfluoroalkyl 
sulfonamides 
(FOSAs) 
 
2-(N-Methylperfluoro-1-
octanesulfonamido)- ethanol MeFOSE 
Pe
rf
lu
or
in
at
ed
 c
om
po
un
ds
 
2-(N-Ethylperfluoro-1-
octanesulfonamido)-ethanol EtFOSE 
Perfluoroalkyl 
sulfonamidoethanols 
(FOSEs) 
4:2 fluortelomer alcohol 4:2 FTOH 
6:2 fluortelomer alcohol 6:2 FTOH 
8:2 fluortelomer alcohol 8:2 FTOH 
10:2 fluortelomer alcohol 10:2 FTOH 
Fluorotelomer alcohols 
(FTOHs) 
N
eu
tra
l P
FC
s 
6:2 fluorotelomer unsaturated 
carboxylate 6:2 FTUCA 
8:2 fluorotelomer unsaturated 
carboxylate 8:2 FTUCA 
10:2 fluorotelomer unsaturated 
carboxylate 10:2 FTUCA 
Fluortelomer unsaturated 
carboxylates (FTUCAs) 
6:2 fluorotelomer sulfonate 6:2 FTS P
ol
yf
lu
or
in
at
ed
 c
om
po
un
ds
 
8:2 fluorotelomer sulfonate 8:2 FTS 
Fluortelomer sulfonates 
(FTSs) 
Io
ni
c 
PF
C
s 
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1.2 Production and use 
PFCs have mainly been produced using two different processes, electrochemical 
fluorination (ECF) and telomerisation. In the ECF process an electric current is used to 
fully fluorinate the hydrocarbons dispersed in hydrogen fluoride. The predominant chain 
length corresponds to the alkyl chain length of the hydrocarbon. Because the process is 
neither effective nor selective, it yields numerous by-products including different chain 
length and branched isomers (Schultz et al. 2003). A lack of isomeric purity is a signature 
of this process. In the telomerisation process tetrafluoroethylene reacts with intermediate 
perfluoroalkyliodides. The fluoroalkyl chain generated during telomerisation processes 
are all linear and contain only even number of fluorinated carbons (Schultz et al. 2003). 
The production of PFCs using the ECF process started around 1947, increased 
throughout the 1990s and maximum production was reached in 2000 (3M Company 
2003;Kissa 2001). The ECF process was mainly used to produce PFOA and a line of 
perfluorooctane sulfonyl fluoride (PFOSF)-based products including PFOS. The global 
production of these products in 2000 was estimated to be around 3535 tonnes (Stock et al. 
2010). In 2000, a phase-out of production of “perfluorooctanyl” compounds was 
announced by the main US manufacturer, 3M (3M Company 2000) after PFOS was found 
to be widespread in human populations and wildlife (Hansen et al. 2001;Kannan et al. 
2001a;Kannan et al. 2001b). Subsequently, the US Environmental Protection Agency (US 
EPA) requested eight manufacturers to voluntarily eliminate their production and use of 
PFOA, its precursors and related chemicals (US EPA 2006a). For the period 1970 to 
2002, Paul et al. (2008) estimated the total global production of PFOSF to be 96 000 
tonnes. The FTOHs have been produced using the telomerisation process from the 1970s 
(Prevedouros et al. 2006). The annual production of FTOHs from 2000-2002 was 
estimated to be 5 000-6 500 tonnes, while a volume of around 12 000 tonnes in 2004 was 
estimated (Stock et al. 2010).  
In 2004, the Climate and Pollution Agency (former Norwegian Pollution Control 
Authority) conducted a survey to explore uses of PFCs in Norway (Huse 2004). The 
largest quantities of PFCs were found to be used in fire extinguishers (15 tonnes/year) 
and textile protection (7-10 tonnes/year). The total annual amount of PFCs used was 
estimate to be in the range 23.2 to 26.2 tonnes (Huse 2004). 
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1.3 Physical-chemical properties and 
pharmacokinetics 
Taves (1968) reported that human serum could contain organic fluorine. However 
it was not until 2001 when a sensitive and selective method for determination of PFCs 
had been developed, that the first study could confirm presence of PFCs in human serum 
(Hansen et al. 2001). Shortly after that, it was discovered that PFCs were ubiquitously 
distributed in wildlife (Kannan et al. 2001a;Kannan et al. 2001b). These early findings led 
to serious concerns about the persistence and bioaccumulative properties of PFCs. 
Environmental losses of PFCAs and PFSAs through degradation are negligible 
due to the resistance to degradation (Kissa 2001). In contrast, neutral PFCs such as 
FOSAs, FOSEs and FTOHs, are usually not environmentally persistent, but may be 
transformed to persistent ionic PFCs in the environment (Ellis et al. 2004;Martin et al. 
2006). It is not likely that FTOHs, FOSAs and FOSEs will undergo substantial 
bioaccumulation, as FTOHs and PFOSA have been demonstrated to be rapidly 
transformed and eliminated in fish (Brandsma et al. 2011). Among the ionic PFCs, PFSAs 
have been found to be more bioaccumulative than PFCAs of the same chain length. The 
bioaccumulation is directly related to the length of the carbon chain. PFCAs with seven 
fluorinated carbon or less and PFSAs with six fluorinated carbons or less, have not been 
found to be bioaccumulative (Conder et al. 2008). 
Both neutral and ionic PFCs have been found to be widespread in the environment 
including the Arctic (Butt et al. 2010;Houde et al. 2006). In general, higher 
concentrations have been observed in samples collected close to urbanized/industrialized 
areas (Houde et al. 2006). As PFCs are neither produced nor used in the Arctic, their 
presence must be due to long-range transport. FOSA/FOSEs and FTOHs are found 
predominately in the air, while PFSAs, PFCAs and FTUCAs are mainly found in the 
aquatic phase (Stock et al. 2010). 
Animal studies demonstrate that PFCs are well absorbed after oral administration 
(Hundley et al. 2006;Lau et al. 2007). It has been shown that FTOHs can be 
biotransformed to PFCAs (Nabb et al. 2007) and FOSA/FOSEs to PFSAs (Tomy et al. 
2004). Ionic PFCs are distributed primarily in the extracellular space (Lau et al. 2007). 
Further they associate with proteins such as albumin and liver fatty acid-binding protein 
(Han et al. 2003), and undergo extensive uptake from enterohepatic circulation (Lau et al. 
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2007). The highest concentrations are found in blood, liver and kidney (Hundley et al. 
2006;Johnson et al. 1979;Seacat et al. 2002;Seacat et al. 2003).  
The ionic PFCs are primarily excreted through urine (Hundley et al. 2006). Rates 
of elimination differs considerably between species and sexes of a single species, and 
humans are thought to be very slow eliminators of PFCs compared to other species (Lau 
et al. 2007). This has been studied in retired fluorochemical production workers who had 
high initial serum concentrations (arithmetic mean = 799 ng/mL PFOS) (Olsen et al. 
2007). Depuration followed a first-order kinetic, and geometric means of half-lives were 
4.8 years for PFOS, 7.3 years for PFHxS, and 3.5 years for PFOA. The half-life range for 
PFOA was later confirmed in studies of general populations from Germany and the US 
exposed to PFOA through contaminated drinking water (Bartell et al. 2009;Hölzer et al. 
2009; Seals et al. 2010). Two recent studies on exposures of professional ski waxing 
technicians indicated long elimination half-lives for PFNA, PFDA and PFUnDA as well 
(Freberg et al. 2010;Nilsson et al. 2010). In contrast the half-life of PFBS in six 
occupationally exposed workers was found to be around one month (Olsen et al. 2009a).  
1.4 Toxicity and health effects 
The toxicity of ionic PFCs, with special emphasize on PFOS and PFOA, have 
been reviewed by Lau et al. (2007) and Kennedy et al. (2004). Hepatotoxicity, 
developmental toxicity, immunotoxicity, neonatal mortality as well as hormonal effects 
have been demonstrated in animal studies. For instance, repeat-dose studies of PFOS in 
rodents and nonhuman primates indicated a potential to reduce body weight and body 
weight gain, increase liver weight, and reduce serum cholesterol. Similar effects have 
been seen for PFOA, except that no reduction in serum cholesterol was observed for 
nonhuman primates (Lau et al. 2007). A steep dose-response curve for mortality of PFOS 
was observed for sexual mature rats and primates (Lau et al. 2007). In a draft risk 
assessment, the US EPA concluded that “evidence was suggestive that PFOA is 
carcinogenic in humans” (US EPA 2005), and the majority of the EPA scientific advisory 
board members reviewing this draft concluded that PFOA was “likely to be carcinogenic 
in humans” (US EPA 2006b). 
Several epidemiological studies have been conducted to investigate relationships 
between exposure to ionic PFCs, especially PFOS and PFOA, and possible health 
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outcomes. Among the outcomes studied are diabetes, cardiovascular diseases, 
cerebrovascular disease, elevation in uric acid, cholesterol level, thyroid function, 
immune function, liver and kidney function, sex hormones as well as reproductive and 
developmental outcomes as reviewed by Olsen et al. (2009b) and Steenland et al. (2010). 
The studies comprised wide ranges of exposures from highly exposed workers to 
background exposed populations. Occupational studies were often hampered by small 
sample sizes and the healthy worker effect. Several of the epidemiological studies were of 
the cross-sectional type, and it has been criticised that causal relationships between 
exposure and outcome could not be clearly established (Steenland et al. 2010).   
1.5 Regulations 
Based on the persistence, bioaccumulation potential, toxicity and the possibility of 
long range transport, PFOS, its salts as well as known precursors are regulated both 
nationally and internationally. In 2006, the European Union adopted Directive 
2006/122/ECOF which restricts marketing and use of these chemicals (European Union 
2006). PFOS and its salts were also found to fulfil the criteria of the Stockholm 
Convention on persistent organic pollutants (POPs), and were included in the list of 
restricted chemicals in 2009 (Annex B) (Stockholm convention on Persistent Organic 
Pollutants 2009). In Norway, it was forbidden from April 2007 to produce, import or sell 
impregnating agents and fire fighting foams containing 0.005 weight % or more of PFOS 
and related substances. Further, from July 2007 it was also forbidden to produce, import 
or sell textiles and other coated materials with concentrations of PFOS or related 
chemicals of 1 g/m2 or higher (Miljøverndepartementet 2007). The US EPA and eight 
major industrial companies launched the “2010/15 PFOA Stewardship Program” in 2006. 
In this program, the companies committed themselves to reduce global facility emissions 
and product content of PFOA and related chemicals by 95 percent by 2010, and to work 
toward eliminating emissions and product content by 2015 (US EPA 2006a). 
1.6 Exposure assessment 
The process of evaluating whether or not a population is exposed to a certain 
chemical to an extent that might cause adverse health effects, is called risk assessment. A 
 7
risk assessment can be divided in four steps, hazard identification, exposure assessment, 
effect assessment and risk characterisation (van Leeuwen and Vermeire 2007). This is 
illustrated schematically in Figure 1. 
 
 
 
 
 
 
Figure 1. Schematic illustration of the four steps included in a risk assessment 
The exposure assessment is important to gain insight in the concentrations/doses 
to which human populations are exposed to a certain chemical. There are two ways of 
performing an exposure assessment: 
1. Measure concentrations of relevant chemicals in different exposure media (e.g. 
food, air and drinking water) and combine these concentrations with exposure 
factors (e.g. inhalation rate and volume/amount consumed). Such intake 
calculations give information on the external doses we are exposed to.  
 
2. Measure concentrations of relevant chemicals in a suitable biological matrix (e.g. 
blood, breast milk and urine). This is called human biomonitoring. The measured 
concentrations are used to calculate the body burden (total amount in the body) of 
the chemicals based on knowledge on distribution of these chemicals in the human 
body. Such calculations give information on the internal doses.  
 
For POPs, the internal dose reflects an integrated exposure over time comprising 
various sources and pathways. Biomonitoring data (e.g. blood concentrations) will also 
take individual differences into consideration (e.g. age and gender). In addition to giving 
Exposure assessment
Risk characterisation
Hazard identification
Effect assessment
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information on the internal dose of a chemical, biomonitoring is also applicable for 
identifying populations that might be at a higher risk, and for monitoring the efficacy of 
measures taken to reduce the environmental pollution. However, adequate collection of 
biological specimen can be resource-intensive. Further, biomonitoring does not give any 
information on the relative importance of different exposure pathways, which is of high 
importance when selecting appropriate actions to minimise exposure. Thus, the methods 
using internal and external doses are complementary.  
1.7 Human biomonitoring (internal dose) 
Following the first report of PFCs in human serum in 2001 (Hansen et al. 2001), a 
large number of studies have been conducted to explore ranges of PFCs in different 
populations. The pharmacokinetic data on PFCs suggest blood as a suitable sample matrix 
for monitoring the internal exposure of PFCs (Butenhoff et al. 2006). Both whole blood, 
plasma and serum have been used for biomonitoring. Whole blood has the advantage of 
representing the entire circulating fluid, but is impractical from an analytical point of 
view. A study by Ehresman et al. (2007) showed that whole blood concentrations can be 
converted to plasma or serum concentrations using a conversion factor of 2. In contrast 
Kärrman et al. (2006) found mean plasma to whole blood ratios of between 1.1 and 1.4 
indicating partial distribution to cellular components. Further, the neutral PFOSA 
distributed preferentially to the cellular compartment with a plasma-to-whole blood ratio 
of 0.2.  
Elevated serum concentrations have been seen in fluorochemical production 
workers, with mean concentrations of both PFOS and PFOA in the range of 500 to 7 000 
ng/mL (Fromme et al. 2009). Increased PFOA concentrations have also been observed in 
a population living close to a manufacturing site (Emmett et al. 2006). Further, two 
Nordic studies have seen elevated concentrations of PFCAs in serum from professional 
skiwaxers (Freberg et al. 2010;Nilsson et al. 2010). No clear regional differences have 
been observed for general populations. However, there are indications of lower 
prevalence of PFCs in low income countries and slightly higher concentrations in North 
American populations than for European, Asian and Australian populations (Fromme et 
al. 2009;Kannan et al. 2004). Studies on general European populations report serum 
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PFOS concentrations in a range from 1 to 116 ng/mL and PFOA concentrations from 0.5 
to 40 ng/mL around year 2000 (Fromme et al. 2009).  
Several biological factors may influence the body burden of PFCs, including age, 
gender and ethnicity. An increase of contaminant levels in body fluids with age has been 
well documented for polychlorinated legacy POPs, such as polychlorinated biphenyls 
(PCBs) (Laden et al. 1999), however for PFCs, the age dependency seems to be more 
questionable (Fromme et al. 2009). Differences in blood concentrations of PFOS or 
PFOA between sexes have been observed in the majority of studies, but the findings are 
not entirely consistent (Fromme et al. 2009). A study from the US, indicated ethnic 
differences in PFC body burdens with mean serum concentrations of Mexican Americans 
lower than for non-hispanic whites (Calafat et al. 2007). Serum concentrations of PFCs 
are also influenced by other factors e.g. consumption of certain types of food. In a study 
from Poland, Falandysz et al. (2006) showed that individuals who reported a high intake 
of fish had higher concentrations of PFCs in their blood than those from who did not 
report high intake of fish. Results from Denmark showed positive associations between 
PFOS concentrations in serum and consumption of red meat, animal fat and snacks 
(Halldorsson et al. 2008). 
Animal studies as well as human studies have demonstrated that PFCs can cross 
the placental barrier and thereby expose the foetus (Apelberg et al. 2007;Hinderliter et al. 
2005;Inoue et al. 2004a;Monroy et al. 2008). PFCs have also been detected in breast 
milk, and in a limited study on 12 primiparous Swedish mothers, PFOS concentrations in 
breast milk of around 1% of those in serum were found (Kärrman et al. 2007). In a review 
by Fromme et al. (2009) ranges of PFC concentrations in breast milk from various studies 
are summarised. The reported concentrations of PFOS ranged from 0.01 to 0.47 ng/mL 
breast milk, while the concentrations of PFOA varied between 0.05 and 0.61 ng/mL. 
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1.8 Exposure pathways (external dose) 
Humans can be exposed to PFCs via different pathways, as illustrated in Figure 2. 
 
 
 
 
 
 
 
 
Figure 2. Sketch of possible exposure pathways to PFCs for humans 
1.8.1 Exposure through diet 
In general, food might be polluted with PFCs present in the environment. Meat 
etc. can also be contaminated through the domestic animals’ feed. Further, it has been 
demonstrated that PFCs can migrate from food packaging and non-stick cookware which 
thus represents additional sources of exposure from food (Begley et al. 2005;Sinclair et 
al. 2007). Both ionic and neutral PFCs have been determined in samples of food as 
summarised by Egeghy and Lorber (2010), Fromme et al. (2009) and Vestergren and 
Cousins (2009). Ionic PFCs have in general been found in highest concentrations in 
samples of fish and shellfish (Ericson et al. 2008;Tittlemier et al. 2007), while the highest 
amounts of FOSAs have been observed in composite samples of fast food (Tittlemier et 
al. 2006). 
Ionic PFCs have been determined in drinking water from several countries, and 
concentrations of PFOS and PFOA are usually in the low ng range (Mak et al. 2009). 
However, higher concentrations have been observed in areas with high industrial activity 
Dust
Air
DietHuman
Dermal 
contact
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(Ericson et al. 2009), near facilities manufacturing fluoropolymers (Emmett et al. 2006) 
and in an area where a contaminated soil conditioner had been applied on agricultural 
land (Hölzer et al. 2008). 
1.8.2 Exposure through ingestion of house dust and inhalation of air 
The large historical production volumes and widespread applications of PFCs in 
consumer products represent a potential for contamination of the indoor environment. 
Vapour pressures of PFCAs and PFSAs in dissociated forms are expected to be low, thus 
exposure from air primarily occurs through inhalation of neutral PFCs (Stock et al. 2010). 
Concentrations of PFCs in indoor air usually exceed the concentrations in outdoor air 
considerably, and thus indoor air is also suggested to be a source of PFCs in outdoor air 
(Harrad et al. 2010). Due to the low concentrations in outdoor air, exposure through 
inhalation of air is mainly through indoor air. Concentrations of PFCs in indoor air have 
been found to vary a lot between homes, e.g. in a study from Canada a range from 261 to 
28 900 pg/m3 was observed for 8:2 FTOH (Shoeib et al. 2008). 
Ingestion of house dust is a potential exposure source for PFCs. In most studies on 
house dust ionic PFCs have been determined (Harrad et al. 2010), but neutral PFCs have 
been measured in certain cases as well (Shoeib et al. 2005). As for indoor air, the 
concentrations in house dust are quite variable. The distribution pattern is often following 
a lognormal distribution, with some samples having concentrations far exceeding the 
mean and median values of the dataset (Harrad et al. 2010). Kubwabo et al. (2005) 
reported concentrations of PFOS in the range 2.3 to 5 065 ng/g dust. 
1.8.3 Dermal exposure 
Dermal exposure to PFCs can occur through direct contact with consumer 
products. Three surveys have been conducted in Norway to explore ranges of PFCs in 
clothing (SFT 2006;Grønn hverdag 2010;Schulze and Norin 2006) and both ionic and 
neutral PFCs were detected. PFCs have also been found in carpets and textiles (Washburn 
et al. 2005), waxes and paints (Vejrup and Lindblom 2002;Washburn et al. 2005), food 
contact materials (Begley et al. 2005) and non-stick cookware (Sinclair et al. 2007). 
However, as the dermal absorption of ionic PFCs is thought to be low (e.g. the dermal 
absorption of ammonium perfluorooctanoate was only 0.048% (Fasano et al. 2005)), this 
pathway is thought to give only a minor contribution to the intake of PFCs. 
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1.8.4 Total exposure 
For traditional POPs, such as dioxins and PCBs, the major exposure route for 
general populations is through the diet (Liem et al. 2000). However, as PFCs are used in 
consumer products indoors, the indoor environment could be a considerable source of 
PFCs in humans. Based on available exposure data from the literature, total intakes as 
well as relative proportions of the intakes for adults have been modelled for PFOS and 
PFOA (Egeghy and Lorber 2010;Fromme et al. 2009;Trudel et al. 2008;Vestergren and 
Cousins 2009). These studies indicate that consumption of food is generally the major 
source of exposure for background exposed adults. The contribution of precursor 
compounds (FTOHs, FOSAs and FOSEs) to the exposure of PFOS and PFOA have been 
evaluated by Vestergren et al. (2008), showing that in an intermediate exposure scenario 
2-8% of the PFOS and PFOA exposure is from precursors, while in a high exposure 
scenario 28-80% of the exposure is from precursors. In these modelling studies, intakes 
have been calculated based on 2-3 scenarios by changing the concentrations in the 
exposure medias (e.g. high or low concentration in drinking water) and the exposure 
factors (e.g. high or low dust ingestion rate). So far, no studies have compared intakes 
from multiple exposure sources including dust, air and diet on an individual basis.  
A breast-fed infant will be exposed to considerable amounts of PFCs during the 
breast-feeding period in the first months of life. Based on concentrations in Swedish 
breast milk samples, Kärrmann et al. (2007) estimated the daily intake of PFCs to be 
approximately 200 ng. However, infants may also ingest considerable amounts of dust by 
crawling on the floor and by putting toys and other objects in their mouth. In fact, the 
contribution from dust ingestion was estimated to be about the same as from food 
ingestion for 2 years old children in a study from the US (Egeghy and Lorber 2010). 
Thus, exploring multiple exposure pathways for infants is also important. 
1.9 Comparison of external and internal doses 
(intakes vs blood concentrations) 
As mentioned previously, exposure assessment using only internal or external 
doses have some limitations. However, these two methods give complementary 
information. The validity of the intake calculations can be examined in two ways; by 
exploring associations between calculated intakes and concentrations of PFCs in blood 
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using linear regression analyses, or by comparing calculated intakes with intakes back-
calculated from serum concentrations using a pharmacokinetic (PK) model. In two studies 
where individual dietary intakes of PFCs were estimated and compared with 
corresponding serum concentrations, no significant relationship was found (Fromme et al. 
2007;Kärrman et al. 2009). In the same studies, good agreements between intakes 
calculated using duplicate diet information and back-calculation from serum 
concentrations using a PK model were observed. In a modelling study by Vestergren and 
Cousins (2009) the total intake from multiple exposure pathways was compared to back-
calculated intakes from serum concentrations. An agreement within a factor of 1.5-5.5 
was observed. However, no studies have so far been able to compare biomonitoring data 
with total intakes from multiple exposure pathways for individuals. 
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2. AIM OF THE STUDY 
The aim of this study was to characterise human exposure pathways of 
perfluorinated compounds by comparing estimates of exposure from food, drinking 
water, indoor air and house dust with biomarkers of exposure.  
PFCs are present in many consumer products and are known to accumulate through 
the food chain. The fact that many Norwegians are high consumers of fish (EFSA 2004) 
and spend a lot of time indoors due to the climate, thus makes evaluation of these 
exposure pathways particularly important. Further, Norwegian mothers are among the 
most enthusiastic breast-feeders in the world, and more than 80% of all babies are breast-
fed at the age of six months (Andreassen et al. 2001; Häggkvist et al. 2010). Thus, 
evaluation of the exposure of infants to PFCs through breast-feeding in relation to 
exposure from the indoor environment is also of particular interest in Norway.  
To reach the overall aim, several sub goals were achived:  
 High quality analytical methods to measure PFCs in human serum and breast milk 
were established (Paper 1 and 5) 
 Temporal changes of PFC exposure in Norway were assessed by measuring PFC 
concentrations in pooled samples of serum collected over several decades (Paper 
2) 
 Changes in concentrations of PFCs in Norwegian breast milk during the course of 
lactation were studied (Paper 5) 
 Concentrations of PFCs in samples of serum (Paper 2, 4 and 7) and breast milk 
(Paper 5 and 7) from selected  Norwegian populations were determined 
 Concentrations of PFCs in selected samples of Norwegian food and beverages 
were determined (Paper 3) 
 Ranges of PFCs in paired samples of indoor air and house dust from a variety of 
Norwegian homes were explored (Paper 6) 
 Predictors of serum PFC concentrations were identified (Paper 2, 4, 5 and 7) 
 Dietary intakes of PFCs in selected Norwegian populations were estimated and 
food groups of main influence identified (Paper 3, 4 and 7) 
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 The PFC exposure through indoor environment, via inhalation of indoor air and 
dust ingestion, for a group of  Norwegians was examined (Paper 7) 
 Individual intakes of PFCs for selected groups of Norwegians were compared 
with concentrations of the corresponding PFCs determined in their serum (Paper 
4 and 7) 
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3. SUBJECTS AND METHODS 
This thesis is mainly based on analyses of samples collected in the BROFLEX 
study (described below). In addition, we had access to samples from other studies which 
gave us the opportunity to look further into some aspects related to exposure to PFCs.  
3.1 The BROFLEX study  
A study group of 41 volunteers from the Oslo area in Norway, hereafter called the 
‘BROFLEX study group’, was established. As we also wanted to evaluate exposure of 
infants by analysing breast milk, only women were eligible for this study. The BROFLEX 
study group was restricted in size and geographic area for practical reasons. Colleagues 
from the Norwegian Institute of Public Health (NIPH) and women in the circle of 
acquaintances were invited to participate in the study. The study was approved by the 
Regional Committee for Medical Research Ethics (S-07110a, 2.2007.260). Written 
informed consent was obtained from all the women.   
The following samples/information were collected from each woman/household: 
 blood serum (n = 41) 
 breast milk  (n = 19) 
 indoor air from the women’s residence  (n = 41) 
 house dust from the women’s residence  (n = 41) 
 a questionnaire (n = 41) covering demographic information, different life style 
factors as well as dietary habits (see Appendix 1, in Norwegian)  
 
In addition, samples of selected food and beverages were collected (see below). 
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Figure 3. Overview of the individual samples and information collected in the BROFLEX study 
3.1.1 Collection of blood serum 
Blood was collected either by the womens’ general practitioners or a medical 
laboratory technician at the NIPH. The sampling occurred between August 2007 and May 
2008. Whole blood was collected in vacutainer tubes without anticoagulant, allowed to 
clot by placing in room temperature for 30-120 minutes, centrifuged (2500 rpm) until the 
serum was separated from the cells, and then the serum was transferred to a polyethylene 
(PE) container. If blood was drawn by a general practitioner, the serum was sent to NIPH 
by mail the same day. An amount of 3.5-13 mL of serum was obtained from each woman. 
The samples were stored below -18 °C until analyses. 
3.1.2 Collection of breast milk 
All breast-feeding women were encouraged to donate a sample of breast milk. 
Breast milk was collected by the women themselves. Breast milk was obtained by manual 
expression into a provided, pre-cleaned PE bottle. The mothers were free to collect the 
breast milk whenever they liked during the day, and sampling could occur on consecutive 
days as long as the breast milk was frozen between each sampling. Between 30 and 100 
Blood serum
Indoor air
House dust
Breast milk
Questionnaire with 
information on:
- Demographics
- Life style factors
- Dietary habits
 18 
mL breast milk was obtained from the women. The samples were stored below -18 °C 
until analyses. 
3.1.3 Sampling of indoor air and house dust 
The vapour pressures of PFCAs and PFSAs in their dissociated form are expected 
to be very low (Stock et al. 2010), thus these PFCs are expected to be mainly bound to 
particles. Neutral PFCs have high vapour pressures and are found predominately in the 
gas phase (Stock et al. 2010). Therefore, only neutral PFCs were determined in the 
samples of indoor air, and the ionic PFCs in the samples of house dust. Concentrations of 
the neutral FOSAs/FOSEs were also determined in the samples of house dust, but were 
observed above the limit of quantification (LOQ) only in a few samples and in low 
concentrations, as expected.  
 
Figure 4. Illustration of sampling of indoor air 
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The samples of indoor air and house dust were collected between February and 
May 2008. Airborne PFCs in gaseous and particulate phase were trapped on tubes 
containing polyurethane foam (PUF)-XAD2-PUF using low-volume air samplers, as 
shown in Figure 4. The pump speed was 4 L per minute per tube and the sampling lasted 
for 24 hours. Two parallel tubes were connected to the pump giving a total volume of 
11.52 m3 air sampled. The samples of air and dust were collected on two consecutive 
days in the living room, and house dust was collected by the research team at the end of 
the air sampling period. Deposited dust was sampled from elevated surfaces such as 
bookshelves and window sills. The samples were collected using a vacuum cleaner 
equipped with a special forensic nozzle with a one-way filter housing placed in front of 
the vacuum cleaner tube (see Figure 5).  
 
Figure 5. Illustration of sampling of house dust 
The air sampler tubes as well as the filter housing containing the house dust were 
wrapped in aluminium foil, each sample set packed in a PE bag and stored below -18 °C 
until analyses. Further information on collection of samples is given in Paper 6 and 
Huber et al. (accepted for publication).  
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3.1.4 Sampling of food and beverages 
At the beginning of the BROFLEX study in 2007, the knowledge on 
concentrations of PFCs in Norwegian food and beverages was very limited. Some data on 
fish and shellfish were available in reports from the Climate and Pollution Agency 
(former Norwegian Pollution Control Authority) and the Nordic Council of Ministers 
(Bakke et al. 2007;Bakke et al. 2008;Fjeld et al. 2005;Fjeld et al. 2009;Green et al. 
2008;Kallenborn et al. 2004;Verreault et al. 2007). However, these samples had mainly 
been collected in costal near areas for environmental surveillance purposes. Thus, as a 
part of the BROFLEX study we collected samples of selected food and beverages to 
determine concentrations of PFCs (n=21). Except for drinking water, all samples were 
bought in grocery stores in the Oslo area. The samples comprised lettuce, carrot, potato, 
cheese, margarine, milk, bread, strawberry jam, pork meat, beef, chicken meat, egg, fish 
sticks, canned mackerel, farmed salmon, cod, cod liver, drinking water and tea. With the 
exception of cod, cod liver and drinking water, homogenates of three different brands or 
types were prepared. Samples of drinking water (n=3) were collected from the tap in 
households receiving water from different water works. All homogenates except cod 
liver, drinking water and tea were freeze dried prior to the analyses. Details on collection 
and analysis of these samples are given in Paper 3. 
3.2 Time trend study 
We had access to samples from a serum bio-bank established by the Division for 
Infectious Disease Control at the NIPH. The serum had been sampled from patients at 
different county hospitals, regardless of disease and the reason for hospitalisation, during 
the period 1976 to 2007 and stored below -18 °C. Serum from around 20 individuals were 
included in each pool (except 1997; n=14). The pools representing the years 1976 to 2002 
had been prepared previously and used in a previous investigation (Thomsen et al. 2007), 
while the pools from 2003-2007 were prepared in 2008.  
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Two sample sets were established: 
1. Pools of serum from men 40-50 years of age. One pool was prepared per year 
(1977, 1980, 1981, 1982, 1983, 1985, 1986, 1988, 1989, 1990, 1991, 1993, 1994, 
1995, 1996, 1997, 1999, 2000, 2001, 2002, 2003, 2004, 2005, 2006) 
2. Pools of serum from different age groups (e.g. 0-4, 5-14, 15-24 years) and genders 
collected in four different years (1976, 1987, 1998, 2007) 
 
These samples gave us the possibility of exploring time trends as well as effect of 
age and gender on PFCs concentrations in Norwegian serum samples covering a period of 
almost 30 years. Further details on these samples are given in Paper 2. 
3.3 Depuration rate study 
In a study organised by the Department of Analytical Chemistry at the NIPH, nine 
Norwegian primiparous mothers and one mother breast-feeding her second child collected 
breast milk samples monthly from about two weeks after birth to up to twelve months 
(n=70). Each mother collected between 3 and 10 samples. Three mothers sampled breast 
milk in the period 2001-2003, while six sampled during 2005 and 2006, and one sampled 
in 2008-2009. Concentrations of PFCs were determined in the breast milk samples (n=68) 
to evaluate the changes in concentrations of PFCs during the lactation period. Further 
information on these samples is given in Paper 5. 
3.4 Norwegian Fish and Game Study  
NIPH has in collaboration with the Norwegian Food Safety Authority conducted a 
dietary survey in three parts, with special focus on consumption of fish and game, which 
are known to contain high levels of several environmental contaminants, and may thus be 
important with regard to dietary exposure of such compounds. Details on the Norwegian 
Fish and Game Study (NFG study) are given by Kvalem (2010). In the NFG study Part C, 
samples of serum were collected from a group of persons having a large variation in 
consumption of fish and shellfish. The participants also completed a 12-page food 
frequency questionnaire (FFQ) covering the consumption over the last 12 months for the 
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whole diet, in addition to a one-page query about demographic data. Thus, by determining 
PFCs in these serum samples, we could explore the influence of diet on PFC 
concentrations in serum in further detail. Results from this study are presented in Paper 
4. 
3.5 Analytical methods 
3.5.1 Indoor air and house dust 
Methods for sampling and determination of PFCs in indoor air and house dust 
were established and tested by the Norwegian Institute for Air Research (NILU). The 
collection of the BROFLEX samples was carried out by NIPH, while the PFC analyses 
were performed by NILU using liquid chromatography-time of flight-mass spectrometry 
(LC-TOF-MS) and gas chromatography-mass spectrometry (GC-MS). See Paper 6 and 
Huber et al. (accepted for publication) for further information on determination of PFCs 
in indoor air and house dust. 
3.5.2 Food and beverages 
Samples of food and beverages were randomly purchased from grocery stores in 
Oslo by NIPH. All samples except cod liver, drinking water and tea were freeze-dried at 
NIPH, while MTM at Örebro University performed the PFC determinations according to 
their own procedures using liquid chromatography-triple quadrupole mass spectrometry 
(LC-MS/MS). For further details on determinations of PFCs in food and beverages see 
Paper 3. 
3.5.3 Serum and breast milk 
To accomplish this study, analytical methods for the determination of PFCs in 
human serum and breast milk had to be established at NIPH. A broad range of 
perfluorinated compounds likely to be present in human samples, were to be included in 
the methods. The established methods including results of the validation experiments are 
further discussed in paragraph 4.1 as well as in Paper 1 (serum) and Paper 5 (breast 
milk). 
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3.6 Quality control  
To assure high quality of the determinations, all real samples (indoor air, house 
dust, food, drinking water, serum and breast milk) were analysed along with procedural 
and/or field blanks. No PFCs were observed above LOQ in any of the batches analysed 
for determinations of PFCs in serum or breast milk. For food and beverages the LOQs 
were calculated as three times the standard deviation of the method blanks, and none of 
the samples were thus corrected for PFCs in the blanks. A few PFCs were observed above 
the LOQs in the blanks analysed together with the samples of indoor air and house dust. 
Thus the concentrations of these PFCs were corrected by subtracting the mean blank 
concentrations. 
In-house quality control samples were analysed together with the samples of food, 
serum and breast milk. In addition, the methods were also tested by participation in 
interlaboratory comparisons (ILC) or by analysing reference samples from previous ILCs. 
The results of these analyses were found satisfactory, and are presented along with the 
results in Paper 1, 2, 3, 4, 5 and 7. No in-house or external control samples were 
available for house dust or indoor air. However, the method for determination of PFCs in 
indoor air and house dust had previously been tested by spiking experiments and had 
been found adequate (Berger and Haukas 2005;Huber et al. accepted for publication).  
3.7 Statistics 
SPSS version 17.0 (SPSS Inc. Chicago, IL, USA) was used for the statistical 
analyses. A significance level of p = 0.05 was used. Bivariate correlations were explored 
using either Pearson Correlation or Spearman’s Rank Correlation depending on the 
distribution of the data sets (Paper 2, 4, 6 and 7). In the time trend study (Paper 2) the 
influence of sex on the concentrations of PFCs in serum was assessed using a paired 
sample t-test. Multiple linear regression (MLR) analyses were performed to identify 
predictors of PFCs in serum (Paper 4 and 7), indoor air or house dust (Paper 6), as well 
as for assessing the relationship between estimated intakes and concentrations of PFCs in 
serum (Paper 4 and 7). To estimate the slope of the concentrations over time in the study 
on depuration rates (Paper 5), we used linear mixed effect models. Further details related 
to the statistical methods used are given in the papers (Paper 2, 4, 5, 6 and 7). 
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3.8 Intake calculations 
In this thesis, intakes have been estimated from consumption of food and drinking 
water, ingestion of dust and inhalation of indoor air. Dietary intakes have been estimated 
for up to ten PFCs, while intake calculations from ingestion of dust and inhalation of air 
have been performed only for PFOS and PFOA. For all intake estimates 100% absorption 
was assumed. 
3.8.1 Dietary intakes 
Dietary intakes have been estimated in three populations (Paper 3, 4 and 7) 
presented in this thesis. In Paper 3, only PFC concentrations measured in food and 
beverages collected in the BROFLEX study were used. These concentrations were 
combined with consumption data for the Norwegian general adult population from the 
NORKOST study (Johansson and Solvoll 1999). Dietary intakes for ten PFCs were 
estimated using consumption data for adults in general, and in addition intakes divided by 
sexes and three age groups (16-29, 30-59, 60-79 years) were also explored. For the NFG 
study, individual intakes of PFOS, PFOA and PFUnDA were estimated for all 
participants using information from the FFQ as well as all available information on PFC 
concentrations in Norwegian food and beverages (Bakke et al. 2007;Bakke et al. 
2008;Fjeld et al. 2005;Fjeld et al. 2009;Green et al. 2008;Kallenborn et al. 2004;Verreault 
et al. 2007;Paper 3). Due to limited data on concentrations of the other PFCs in 
Norwegian food and beverages, calculations were limited to these three PFCs. Similar 
calculations were performed for PFOS and PFOA, for the women in the BROFLEX study 
group.  
3.8.2 Intakes from ingestion of dust 
Intakes of PFOS and PFOA through dust ingestion were calculated on an 
individual basis for the women in the BROFLEX study group using the concentrations of 
PFCs determined in their house dust and dust ingestion rates found in the literature. 
Harrad et al. (2010) have pinpointed the high uncertainty in dust ingestion rates 
published, as studies so far primarily have been designed for deriving soil ingestion rates 
(Stanek et al. 1997;Stanek and Calabrese 1995). Thus, we decided to use three different 
scenarios, assuming dust ingestion rates of either 50, 100 or 200 mg/day (US EPA 1997). 
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3.8.3 Intakes from inhalation of indoor air 
For individual intakes of PFOS and PFOA from inhalation of indoor air, only 
biotransformations of FOSA/FOSEs to PFOS and FTOHs to PFOA have been considered. 
Similarly to ingestion of dust, we decided to establish intakes based on three scenarios 
using different biotransformation factors. The intakes were calculated by multiplying the 
sum FTOH or sum FOSA/FOSE concentrations with the respective biotransformation 
factor and inhalation rate. In accordance with Vestergren et al. (2008) factors of 0.01 
(scenario 1), 0.2 (scenario 2) and 1 (scenario 3) were chosen for the biotransformation of 
FOSA/FOSEs to PFOS while 0.0002 (scenario 1), 0.005 (scenario 2) and 0.017 (scenario 
3) were used for the biotransformation of FTOHs to PFOA. Similar to Egeghy and Lorber 
(2010), inhalation rates of 13.3 and 6.8 m3 air per day were used for the women and 
infants, respectively. 
3.8.4 Intakes through consumption of breast milk 
Individual intakes through consumption of breast milk were calculated by 
multiplying the breast milk concentrations with a daily consumption of 700 mL breast 
milk. 
3.8.5 Total intakes for the women 
Three total intakes were calculated per individual, based on different scenarios. 
Due to high uncertainty regarding dust ingestion rates and biotransformation factors, 
three different exposure scenarios were established both for dust ingestion and inhalation 
of air. Intakes from food and drinking water were regarded as sufficiently certain, thus 
only one intake was calculated per individual for these exposure sources.  
The three following total intakes were estimated: 
 S1 (Total intake scenario 1): intake food + intake drinking water + intake dust (scenario 1) + intake air (scenario 1) 
 S2 (Total intake scenario 2): intake food + intake drinking water + intake dust (scenario 2) + intake air (scenario 2) 
 S3 (Total intake scenario 3): intake food + intake drinking water + intake dust (scenario 3) + intake air (scenario 3) 
3.8.6 Total intakes for the infants 
Norwegian governmental authorities recommend exclusive breast-feeding the first 
half year (Norwegian Directorate of Health 2008), and more than 80% of all babies are 
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breast-fed at the age of six months (Andreassen et al. 2001;Häggkvist et al. 2010). 
Further, at this age infants may also ingest considerable amounts of dust by crawling on 
the floor and by putting toys and other objects in their mouth. Thus, for exposure of 
infants we chose to assess children six months of age, and included consumption of breast 
milk, ingestion of dust and inhalation of indoor air. Similarly to the total intakes for the 
women, three total intakes were calculated. The intake from breast milk consumption was 
identical for all three intakes. The same biotransformation factors and dust ingestion rates 
as for the women were used, while the inhalation rate was half of that for adults. 
The three following total intakes were estimated: 
 S1 (total intake scenario 1): intake breast milk + intake dust (scenario 1) + intake air (scenario 1) 
 S2 (total intake scenario 2): intake breast milk + intake dust (scenario 2) + intake air (scenario 2) 
 S3 (total intake scenario 3): intake breast milk + intake dust (scenario 3) + intake air (scenario 3) 
3.9 Comparisons between external and internal 
dose using PK modelling 
The measured serum concentrations were compared with concentrations 
calculated from the total daily intakes using a first-order PK model as described by Egegy 
and Lorber (2010). In this model, the blood serum concentration is predicted as a function 
of dose, elimination rate and volume of distribution (i.e. the total amount of a PFC in the 
body divided by its concentration in the serum). This model is only applicable under 
steady state conditions, which was assumed. The dose was set to the total intakes of 
PFOS and PFOA (scenario 1, 2 and 3) in ng/kg bw/day. Elimination half-lives of 4.8 
years (Olsen et al. 2007) and 2.3 years (Bartell et al. 2009) were applied for PFOS and 
PFOA, respectively, while the volumes of distribution were set to 220 mL/kg for PFOS 
and 140 mL/kg for PFOA, according to Andersen et al. (2006).  
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4.  RESULTS AND DISCUSSIONS 
4.1 Methods for determination of PFCs in serum 
and breast milk 
In recent years several reviews have been published summarising methodologies 
for determination of PFCs (de Voogt and Saez 2006;Martin et al. 2004;van Leeuwen and 
de Boer 2007;Villagrasa et al. 2006). The first compound specific method for 
determination of PFCs in human serum was published by Hansen et al. (2001). This 
method included addition of an ion-paring agent to serum, extraction with methyl-tert-
butylether, filtration and determination using liquid chromatography – tandem mass 
spectrometry in negative electrospray ionisation mode (ESI). This sample preparation 
method was time consuming, laborious and difficult to automate (van Leeuwen and de 
Boer 2007). Much effort has been used in the field, to develop more efficient methods 
which required less manual handling. This has resulted in development of methods using 
off-line solid phase extraction (SPE) (Kärrman et al. 2005;Kuklenyik et al. 2004), as well 
as methods using column switching LC-MS/MS (Holm et al. 2004;Inoue et al. 
2004b;Kuklenyik et al. 2005). The methods using column switching LC-MS/MS are 
advantageous as they require a minimum of manual handling and are fast and were thus 
used as a starting point for developing a method for determination of PFCs in human 
serum. The method developed for serum was then modified to be applicable for breast 
milk. We were aiming at developing methods which were accurate, precise, fast and 
required small amounts of sample. These criteria were used as a basis for the method 
development process.  
At our laboratory we had access to a standard column switching LC-MS/MS. 
Berger et al. (2004) compared three types of LC-MS instruments for analysis of PFCs, 
and concluded that LC-MS/MS instruments operated in negative ESI mode were suitable 
for determination of PFCs. One of the major advantages of that method is the opportunity 
to use MS/MS technology and multiple reaction monitoring (MRM) (Berger et al. 2004). 
Our aim was to establish a serum method comprising the following PFCs; PFBS, PFHxS, 
PFHpS, PFOS, PFDS, PFBA, PFPeA, PFHxA, PFHpA, PFOA, PFNA, PFDA, PFUnDA, 
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PFDoDA, PFTrDA, PFTeDA, PFOSA, MeFOSA, EtFOSA, MeFOSE and EtFOSE. The 
method for breast milk was limited to PFCs which had been found in considerable 
concentrations in human serum (i.e. PFOA, PFNA, PFDA, PFUnDA, PFHxS, PFHpS and 
PFOS). 
The method development started with optimisation of MS parameters to achieve 
high sensitivity of all PFCs in both selective ion monitoring (SIM) mode and MRM 
mode. MeFOSE and EtFOSE had low sensitivity in both SIM and MRM mode and were 
thus left out of the method. Further, we discovered that the sensitivity of PFSAs and 
FOSAs were not sufficient in MRM mode. An approach called ‘pseudo MRM’ was then 
explored (Andreoli et al. 1999). With this ‘pseudo MRM’ technique, the parent ion is 
measured after application of a fragmentation voltage leading to fragmentation of 
interfering species but not the analyte. The experiments resulted in higher responses of 
both PFSAs and FOSAs, and thus, the ‘pseudo MRM’ approach was used for these 
compounds.  
As an initial step in the pre-treatment of serum, proteins are usually removed by 
precipitation using organic solvents such as acetonitrile (Holm et al. 2004;Inoue et al. 
2004b) or organic acids like formic acid (Kärrman et al. 2005). However, Kuklenyik et al. 
(2005) developed a method where no protein precipitation was required. The serum was 
just diluted with 0.1M formic acid. In our initial experiments with sample matrix, we tried 
this approach, but observed that the back-pressure on the SPE column increased between 
each injection and had to be replaced very frequently. This problem was solved by 
precipitation of the proteins using methanol prior to injection on the column-switching 
LC-MS/MS system. Also for precipitation of proteins in breast milk, organic solvents and 
organic acids have been used (Kärrman et al. 2007;Völkel et al. 2008), but enzymatic 
hydrolysis of proteins has also been applied (Mosch et al. 2010). We found that the 
proteins in breast milk were not completely precipitated using methanol, and thus a 
stronger precipitation agent, acetonitrile, was used. This was the major modification of 
our serum method to be applicable for analysing breast milk. 
Background contamination of PFCs both from instruments and the laboratory in 
general was identified as one of the major problems related to determinations of PFCs at 
an early stage (Martin et al. 2004;Villagrasa et al. 2006). Such problems were avoided in 
our methods by minimising sample handling and by installing a Hypercarb guard column 
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between each of the LC pumps and the switching valves (Flaherty et al. 2005;Powely et 
al. 2005). 
Thorough validations of the methods for determination of PFCs in both serum and 
breast milk were carried out. The methods were found to have comparable or higher 
sensitivity than what have been reported elsewhere (Hansen et al. 2001;Holm et al. 
2004;Inoue et al. 2004b;Kärrman et al. 2005;Kärrman et al. 2010;Kuklenyik et al. 
2005;So et al. 2006;Tao et al. 2008b;Völkel et al. 2008). The procedural blanks did not 
contain any of the PFCs above the LOQ. Further, the validation experiments proved the 
methods to have sufficient linearity, repeatability and accuracy. The methods have also 
been applied in several ILCs with satisfactory results (results are presented in Paper 1, 2, 
4, 5, and 7). The methods developed were thus found to be applicable for determination 
of a broad range of PFCs in serum and breast milk. Further, due to the limited manual 
handling the methods are appropriate for use in large-scale investigations comprising 
many samples.  
4.2 Internal dose of PFCs 
4.2.1 Concentrations in serum 
Concentrations of PFC in serum have been explored in Paper 2, 4 and 7. In 2007 
when the BROFLEX study began, no information on body burdens of PFCs in 
Norwegians was available, except for a limited study on twelve serum samples from 
women living in Northern Norway (Odland et al. 2005). During this project, 
concentrations of PFCs in serum from Norwegians have been measured in three study 
groups (Paper 2, 4 and 7). First, we conducted a study to explore changes in serum 
concentrations over a time span of around 30 years (Paper 2). In the NFG study group, 
we determined concentrations of PFCs in individual samples of serum from men and 
women between 18 and 79 years with a wide range of seafood consumption, sampled in 
2003 (Paper 4). The third study group comprised samples of serum from the 41 women 
in the BROFLEX study (age 25-46 years), collected between August 2007 and May 2008 
(Paper 7). In Figure 6, concentrations of the eight most prominent PFCs found in these 
samples are presented by year of sampling. For the time trend study, the pools of serum 
from women and men, 25 years of age and above, are shown in the Figure. Both for the 
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NFG samples (red squares) and the BROFLEX samples (green circles), the mean value of 
all samples is presented.  
As can be seen in Figure 6, the PFC concentrations in serum increased from 1976 
until the mid 1990s where they stabilized. For several PFCs decreasing concentrations 
were observed from around 2000. These trends are in accordance with the increasing 
production of PFCs until the phase-out of certain compounds starting in 2000 (Stock et al. 
2010). No clear decline was observed for the long chain PFCAs (i.e. PFNA, PFDA, 
PFUnDA). This could be due to longer half-lives of these PFCs or differences in use. The 
concentrations of PFCs determined in the NFG study and the BROFLEX study fit well 
into the time trends (see Figure 6), and support the results obtained from the pooled 
samples in the time trend study. In a paper by Vestergren and Cousins (2009) our time 
trend data for PFOA, PFNA and PFOS are presented together with data from three US 
studies, showing similar trends. Also in a recent study on Swedish breast milk, similar 
temporal changes were observed for PFHxS, PFOS and PFOA (Sundström et al. 2011). In 
contrast, the PFC concentrations in Australian serum did not change considerably from 
2002/2003 to 2006/2007 (Toms et al. 2009). 
Six PFCs were found in all serum samples from both the NFG study and the 
BROFLEX study, i.e. PFOA, PFNA, PFDA, PFUnDA, PFHxS and PFOS. In these two 
studies and also in the time trend study the highest concentrations (in decreasing order) 
were observed for PFOS, PFOA, PFHxS and PFNA. The concentrations were in the range 
1.8 - 133 ng/mL for PFOS, 0.28 – 22 ng/mL for PFOA, 0.053 - 14 ng/mL for PFHxS and 
< 0.050 - 4.3 ng/mL for PFNA. This is similar to what has been seen in other studies on 
general populations world-wide (Fromme et al. 2009;Houde et al. 2006;Lau et al. 
2007;Vestergren and Cousins 2009) as well as in two other recent Norwegian studies 
(Rylander et al. 2009;Rylander et al. 2010).  
The PFCs in serum from all three study groups included in this thesis were 
strongly intercorrelated. Correlations were observed within the PFCAs and the PFSAs, 
but also between those two groups of PFCs. Similar associations have also been seen in 
other studies world-wide (Kannan et al. 2004;Olsen et al. 2003). As stated by Olsen et al. 
(2003), PFCAs and PFSAs can not be converted directly into each other, thus correlations 
between these groups point to common sources of human exposure to these two PFC 
classes. 
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Figure 6: Concentrations of selected PFCAs and PFSAs in serum (y-axis; ng/mL) from the time 
trend study (pools of men and women  25 years of age), the NFG study (mean, red squares) and 
the BROFLEX study (mean, pink sircles) presented by year of sampling (x-axis; year) 
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The majority of the serum samples in the NFG study, had previously been 
analysed to determine PCBs and polybrominated diphenyl ethers (PBDEs). Strong 
relationships between concentrations of PFCs and PCBs were observed, while significant 
but weaker associations were seen between PFCs and PBDEs. This is in accordance with 
findings by Daillare et al. (2009). The strong associations between PFCs and PCBs were 
somewhat surprising, as in contrast to PCBs, PFCs do not accumulate in lipids and have 
thus been expected to behave differently. However, these findings indicate that the main 
exposure to PFCs occurs through the same pathways as for PCBs, while other sources 
may be important for the PBDEs.  
4.2.2 Concentrations in breast milk 
Concentrations of PFC in breast milk have been examined in Paper 5 and Paper 
7. Only PFOS and PFOA were found above LOQ in the samples. The PFOS 
concentrations were in the range 0.028 - 0.25 ng/mL breast milk, while the corresponding 
range for PFOA was <0.018 - 0.83 ng/mL breast milk. PFCs have not been previously 
determined in Norwegian breast milk samples, but the concentrations found are similar to 
what has been reported in other studies (Fromme et al. 2009;Fromme et al. 2010;Kärrman 
et al. 2010;Kim et al. 2011;Llorca et al. 2010;Roosens et al. 2010;So et al. 2006).  
In paired samples of breast milk and serum from 19 women in the BROFLEX 
study, linear relationships with correlation coefficients (R2) of 0.63 for PFOS and 0.99 for 
PFOA were observed. Further, the concentrations of PFOA and PFOS in breast milk were 
found to be 3.8 and 1.4% of the serum concentrations on volume basis, respectively. Also 
in two studies from Sweden (n=12) and Germany (n=44) positive correlations between 
concentrations of PFOS in serum and breast milk were observed, and around 1% the 
concentrations in serum were found in breast milk (Fromme et al. 2010;Kärrman et al. 
2006). In a study from Korea (n=17), no significant relationships between concentrations 
of PFCs in breast milk and serum were observed (Kim et al. 2011). However the 
concentrations of PFOA and PFOS in breast milk were 3.4 and 0.5% of the serum 
concentrations, respectively. Despite the limited number of samples included in all these 
studies, the relative proportions of PFOS and PFOA in breast milk in relation to serum are 
similar.  
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Predominantly breast-fed infants consume a relatively high volume of breast milk 
daily. Thus, a considerable amount of the women’s body burden of PFCs can be 
presumed to be eliminated during the course of lactation, even though the concentrations 
of PFCs in breast milk are low. Therefore the concentrations of PFCs in breast milk are 
expected to decrease during the lactation period. To verify this, concentrations of PFCs in 
samples from the depuration study were determined, and depuration rates calculated using 
linear mixed effect models. We found that the concentrations of PFOS and PFOA 
decreased significantly with around 3.8 and 7.8% per month of lactation. In a German 
study, breast milk was collected by mothers on a monthly basis in five months, but no 
significant downward trend was observed for PFOS in these samples (Fromme et al. 
2010). The detection frequency of PFOA in that study was only 2%, thus no trends could 
be explored. The discrepancy between our study and the German study could be due to 
the low number of women included in both studies, as well as possible differences in 
breast-feeding frequency and sampling strategy. According to our models the reduction in 
PFOS concentration during five months would only be around 20%, thus the choice of 
statistical methods as well as the analytical precision may also influence the findings. 
4.2.3 Isomers of PFOS 
When using the ECF process for manufacturing, the PFC-products contain 
branched isomers (Kissa 2001). In this thesis, the relative contribution of branched PFOS 
isomers to the total amount of PFOS has been determined in serum samples from the time 
trend study (Paper 2) and the BROFLEX study (Paper 7), as well as in breast milk from 
the depuration rate study (Paper 5) and the BROFLEX study (Paper 7). In Table 2 is 
presented the mean and ranges of the relative proportion of branched PFOS isomers in the 
samples.  
Table 2. Relative proportion of branched PFOS isomers (%) in samples of breast milk and serum 
(mean and ranges) 
Study Relative proportion of branched PFOS isomers, % 
 Min Max Mean 
Serum, time trend study  22 47 32, 36, 40 and 43* 
Serum, BROFLEX study 14 50 22 
Breast milk, depuration rate 
study  
6 36 18 
Breast milk, BROFLEX study  9 29 17 
* Mean of pools collected in 1976, 1987, 1998 and 2007 
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Overall, the relative proportions of branched PFOS isomers were in the range 6-
50% of the total PFOS concentrations in the samples. In the time trend samples, the 
relative proportion of branched PFOS isomers increased from 1976 to 2007. The reason 
for this is not known, but in Paper 2 we speculated if this could be due to changes in PFC 
usage during these years or differences in half-lives between linear and branched PFOS 
isomers. However, recent research has shown that branched PFOS isomers have shorter 
half-lives than linear PFOS (Benskin et al. 2009), thus increasing proportions of branched 
PFOS isomers during the period 1976 to 2007 could not be explained by differences in 
half-lives. Benskin et al. (2009) have postulated a hypothesis that isomer specific 
biotransformation rates of PFOS-precursors may explain the common observation of 
enrichment of the branched PFOS isomer profiles in humans. This remains to be 
confirmed. 
The serum samples from the time trend study had a higher mean proportion of 
branched PFOS isomers than observed in the BROFLEX serum samples. However the 
min-max ranges were similar. The difference in mean values remains to be clarified. 
Similar ranges and mean values were found for the two sets of breast milk samples, and 
no statistical difference was seen between serum and breast milk samples in the 
BROFLEX study. The relative amounts of branched PFOS isomers in serum and breast 
milk were independent of the concentrations. 
4.2.4 Predictors of serum concentrations 
Predictors of serum PFC concentrations have been studied in Paper 2, 4, 5 and 7. 
Age, gender and breast-feeding history 
In the time trend study we examined the impact of age and gender on the 
concentrations of PFCs in four different years (1976, 1987, 1998 and 2007). No 
significant differences between genders were observed. Significant correlations between 
age and concentrations of most PFCs were seen in the samples from 2007, while the 
results for the other years were more variable. Strongest associations were observed for 
the PFCs with the longest carbon chains. In the time trend study, no additional 
information about the subjects, which may influence the serum concentrations, was 
available. In the NFG study and the BROFLEX study MLR analyses were performed to 
identify predictors of serum PFC concentrations. This statistical approach has the 
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advantage of being able to explore effects of several variables at the same time. In the 
NFG study both men and women were included, and the ages ranged from 18 – 79 years. 
Further, we had extensive information on the participants’ dietary habits the last 12 
months as well as demographic data. We found an effect of age on all PFCs, when 
adjusting for the other predictors of serum PFC concentrations. In contradiction, a 
significant association between PFC concentration and age was observed only for PFOA 
in the BROFLEX study. However, this might be due to the narrow age span for the 
women in this study group (25-46 years). The BROFLEX study group comprised only 
women, thus differences between genders could not be explored. Gender was included as 
a variable in the MLR models for the NFG study, but was not significant. This might be 
due to the associations to breast-feeding history which probably also explain the variation 
due to sex differences. Scientific papers on the effect of age and gender on concentrations 
of PFCs in serum are not consistent (Lau et al. 2007), and lack of appropriate information 
might be one reason for that. 
Finding breast-feeding history as a significant predictor of PFC concentrations in 
the NFG study was somewhat surprising, as most of the women had not been breast-
feeding for many years. This might indicate that the influence of breast-feeding on PFC 
concentrations in serum is high. This was confirmed in the BROFLEX study, where 
previous breast-feeding was a significant and strong predictor of all PFC concentrations 
in serum, except for PFUnDA. Time since previous breast-feeding gave the strongest 
effect, but duration of breast-feeding also influenced the PFC serum concentrations 
significantly. These findings are supported by the decreasing concentrations of PFCs in 
breast milk during the course of lactation, seen in the depuration rate study. In a study 
from the Danish national birth cohort, the duration of breast-feeding decreased with 
increasing concentrations of PFOS and PFOA in serum during pregnancy (Fei et al. 
2010). Thus, the authors suggested that increased concentrations of PFOS and PFOA may 
reduce the ability to lactate. However, as these associations were not observed for 
primiparous women, they reported that a reverse causation might be possible, with lower 
PFC concentrations in the multiparous women who have breast-feed previous infants for 
a long period of time. Our findings of decreasing PFOS and PFOA concentrations in 
breast milk during the course of lactation, support the explanation of a reverse causation. 
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Diet 
The NFG study was designed to evaluate the effect of diet, particularly fish and 
shell fish, on concentrations of environmental contaminants in serum. The serum 
concentrations of several PFCs were significantly associated with consumption of fish 
liver, lean fish and shrimps. The range between min and max consumption of various fish 
species was much smaller in the BROFLEX study e.g., NFG study; 0-8 g fish liver 
consumed per day while in the BROFLEX study 0-0.22 g fish liver was consumed per 
day. Nevertheless, associations between concentrations of some PFCs in serum and 
consumption of fish liver and shell fish were seen in the BROFLEX study as well. 
Seafood has also been identified as a predictor of serum PFC concentrations in other 
studies (Falandysz et al. 2006;Rylander et al. 2009;Rylander et al. 2010;Weihe et al. 
2008). In the NFG study, also significant correlations between consumption of meat and 
concentrations of PFNA, PFDA, PFHpS and PFOS in serum were found. This is in 
agreement with results from the Danish national birth cohort, where red meat was 
identified as a determinant of PFOS and PFOA concentrations in plasma (Halldorsson et 
al. 2008). In another Danish study, frying as compared to cooking was identified as a 
predictor of PFOS and PFOA concentrations in plasma (Eriksen et al. 2010). We did not 
have access to information on processing methods for foods, and thus we were not able to 
examine this in our studies. Egg was also identified as a predictor of PFC concentrations 
in plasma in the Danish study (Eriksen et al. 2010), but this was neither seen in the NFG 
study nor the BROFLEX study. Seafood and meat are generally the food groups with 
highest concentrations of PFCs (Ericson et al. 2008;Tittlemier et al. 2007; Paper 3), thus 
our findings of these food groups being important predictors of serum PFC 
concentrations, are reasonable.  
Area of residence 
In the NFG study, the participants were recruited from both coastal and inland 
municipalities, and the serum PFC concentrations were found to be significantly higher in 
persons living in coastal municipalities as opposed to inland municipalities. Further 
investigation showed a higher frequency of eating self-caught fish in the coastal areas, 
and this coast-near fish is supposed to have higher concentrations of PFCs than fish 
caught in the open sea. Thus, the difference in serum PFC concentrations between costal 
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and inland counties might be due to different contamination levels of the seafood eaten, 
rather than the place of residence itself. In a recent Danish study, significant differences 
in PFOS and PFOA plasma concentrations between living in Copenhagen or living in 
Aarhus were seen (Eriksen et al. 2010). In this study differences in contamination of air 
and drinking water was suggested to be an explanation for the differences, in addition to 
possible variations in lifestyle. 
Indoor environment 
The BROFLEX study was designed to investigate relationships between 
concentrations of PFCs in serum and indoor air and house dust. Significant positive 
associations were seen for PFHxS and PFOA, and a similar tendency was also seen for 
PFOS, however statistically significance was not reached. This is the first study to 
explore relationships between concentrations of PFCs house dust and serum, thus no 
comparison with literature is possible. In the NFG study, where we modelled the 
influence of diet on PFC concentrations in serum, the lowest explained variances in the 
MLR models were obtained for PFOA and PFHxS. This might be due to house dust being 
a more important source of exposure for PFOA and PFHxS than for the other PFCs. This 
is in accordance with finding the strongest positive associations between serum and house 
dust concentrations for PFHxS and PFOA.  
Concentrations of ionic PFCs in air are expected to be low (Egeghy and Lorber 
2010), thus only neutral PFCs were determined in indoor air. As FOSA/FOSEs may be 
biotransformed to PFOS (Tomy et al. 2004), we explored the associations between 
FOSA/FOSEs in indoor air and PFOS in serum, but found no significant relationships. 
Correspondingly, biotransformation of FTOHs to PFOA can be expected (Nabb et al. 
2007), but no relationships between FTOHs in indoor air and PFOA in serum were seen. 
This may indicate that ingestion of house dust affected the serum concentrations to a 
larger extent than inhalation of indoor air. However, the relationships between serum and 
indoor air involves biotransformation of ‘precursors’ in air to ionic PFCs in serum, and 
thus associations are more complex and maybe more difficult to observe.   
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4.3 External dose of PFCs 
4.3.1 Exposure through diet 
Exposure to PFCs through consumption of food and drinking water has been 
assessed in Paper 3, 4 and 7. 
Concentrations in food and beverages 
Concentrations of a wide range of PFCs were determined in 21 samples of 
Norwegian food and beverages. The concentrations of the ten most prominent PFCs are 
illustrated in Figure 7. Unlike other studies, a wide range of PFCs were detected in the 
samples, probably due to the high sensitivity obtained using the applied method. Both 
PFOS and PFOA were detected in almost all food samples, in the range 0.17 to 310 pg/g 
fresh weight. The concentrations of PFOS and PFOA varied between <0.030 to 9.5 ng/L 
for drinking water and tea. The highest PFC concentrations were found in the samples of 
fish, meat and egg, which are in accordance with findings in other studies (Ericson et al. 
2008;Tittlemier et al. 2007).  
The concentrations found are similar or lower than what has been reported in other 
studies (e.g. Bakke et al. 2007;Berger et al. 2009;Clarke et al. 2010;Del Gobbo et al. 
2008; D'Hollander et al. 2010a; Ericson et al. 2008;Jogsten et al. 2009;Mak et al. 
2009;Nania et al. 2009;Ostertag et al. 2009a;Tittlemier et al. 2007;van Leeuwen et al. 
2009). Factors that could explain differences among studies could be geographical as well 
as temporal differences in use of PFC containing products, analytical methodology and 
sensitivity in the measurements of PFCs in food.  
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Figure 7. Concentrations of PFCs in samples of food and beverages presented in Paper 3  
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Intake estimates 
In Figure 8 dietary intakes of PFOS and PFOA estimated in Paper 3, 4 and 7 are 
presented. The intakes in these three populations are not directly comparable as different 
FFQs have been used. In addition, only the PFC concentrations in food and beverages 
determined within this thesis have been used for the NORKOST intakes. 
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Figure 8. Dietary intake estimates for PFOS and PFOA from Paper 3, 4 and 7  
The mean PFOS intakes varied between 0.26 and 1.5 ng/kg bw/day, while the 
mean PFOA intakes were in the range 0.24 - 0.60 ng/kg bw/day, when assuming a body 
weight of 70 kg (Paper 3).  
The dietary intakes estimated using NORKOST data were also divided by sex and 
age groups. Due to differences in amounts of various foods consumed, decreasing intakes 
were observed with increasing age, and higher intakes were estimated for males than for 
females. In contradiction to this, no age dependency was seen in a study by Ericsson et al. 
(2008). A significant difference in PFOS intakes between men and women was also 
observed in the NFG study, with mean intakes of 1.8 and 1.3 ng/kg bw/day, respectively. 
The PFOA and PFUnDA intakes were similar among men and women. The relative 
proportions of intakes from various food groups were assessed both in the NFG study and 
by using NORKOST data. In the NORKOST population fish and shellfish represented 
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only 8 and 19% of the total intakes of PFOA and PFOS, respectively. In the NFG study 
population fish and shellfish were the largest contributors to the PFOA and PFOS intakes, 
counting for 38 and 81% of the total intakes, respectively (see Figure 9). One plausible 
explanation for this difference is lower concentrations of PFCs in the samples of fish used 
in Paper 3 than in Paper 4 where additional samples were included in the estimations. 
Consumption of fish and shellfish were identified as significant predictors of serum PFC 
concentrations in both the NFG study and the BROFLEX study. Thus, a high relative 
contribution of fish and shellfish to the total PFC intakes as found in the NFG study is 
likely. 
 
 
 
 
 
Figure 9. Relative contribution of different food groups to dietary intakes of selected PFCs for the 
participants in the NFG study 
The intakes estimated in the three populations included in this thesis are similar or 
lower than what has been reported elsewhere (Clarke et al. 2010;Ericson et al. 
2008;Fromme et al. 2007;Kärrman et al. 2009;Ostertag et al. 2009a;Ostertag et al. 
2009b;Tittlemier et al. 2006;Tittlemier et al. 2007). Several factors may explain 
differences in estimated intakes; different contamination levels of PFCs in food and 
beverages, how the non-detects are treated in the data set, as well as different approaches 
used for intake calculations. 
In our studies retrospective dietary assessments has been applied to estimate 
dietary intakes of PFCs. The intakes were estimated by combining information from 
FFQs with concentrations reported in food and beverages. Another method used for 
dietary intake calculation is the duplicate diet approach. In this approach the participants 
prepare and save identical portions of all consumed food and beverages consumed over a 
selected period of time. The duplicate diet approach have the advantages of obtaining 
accurate information on the quantity of food consumed, and the PFC concentrations are 
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determined in food which is identical to that consumed. However, this method imposes a 
large effort for the participants, and is very expensive. Thus, for duplicate diet studies 
collection of food is generally performed for a limited number of days (e.g. 7 days) and 
will only be representative for this period. Next, determination of PFCs in composite 
samples of different food types can be challenging due to the complexity of the matrix, 
and also because of ’dilution’ of composites with food containing very low levels of PFCs 
(Tittlemier et al. 2007). Retrospective dietary assessment methods usually ask about food 
and beverages consumed in a larger time-span (e.g. 3-12 months back in time) and are 
advantageous with respect to obtaining information on foods and beverages which are not 
eaten very frequently. Further, this method gives information on the average dietary 
habits during an extended period of time, which is important for compounds with long 
half-lives.  
4.3.2 Exposure through indoor environment 
Exposure to PFCs through inhalation of indoor air and ingestion of house dust was 
explored in Paper 6 and 7. 
Concentrations in indoor air and house dust 
Concentrations of a broad range of PFCs were determined in paired samples of 
indoor air and house dust from the 41 households included in the BROFLEX study. The 
highest median concentrations of PFCAs in dust were found for PFHxA (28 ng/g), PFNA 
(23 ng/g), PFDoDA (19 ng/g) and PFOA (18 ng/g), while PFOS (3.1 ng/g), PFDS (1.1 
ng/g) and PFHxS (0.60 ng/g) were the predominant PFSAs in dust. With the exception of 
PFPeA, the median concentrations of all PFCAs observed were higher than for the 
PFSAs. The concentrations of PFCAs in house dust were more evenly distributed than the 
PFSAs, where a few samples had considerably higher concentrations than the others (see 
Figure 1 in Paper 6). This was speculated to be due to a greater number of sources of 
PFCAs than PFSAs in indoor environments.  
Compared to other studies, the PFC concentrations in the house dust samples are 
similar or lower than what has been found elsewhere (Björklund et al. 2009;D'Hollander 
et al. 2010b;Goosey and Harrad 2011;Huber et al. accepted for publication;Kato et al. 
2009;Kubwabo et al. 2005;Moriwaki et al. 2003;Shoeib et al. 2005;Strynar and Lindstrom 
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2008;Zhang et al. 2010). Variation in PFC concentrations found among studies can be 
due to different use of products world wide, but as highlighted by Harrard et al. (2010), a 
variety of sampling strategies for house dust exists, which could influence the measured 
concentrations. In our study, the research team collected dust using a vacuum cleaner 
with a filter placed in the front of vacuum cleaner tube. Another commonly used 
approach is to analyse the content in a vacuum cleaner bag, which is either collected by 
the household residents or a research team. With respect to the sampling area, we 
collected dust from all elevated surfaces in the living room once. In some studies, when 
vacuum cleaner bags have been donated by the households, dust has been collected 
wherever the vacuum cleaner has been used during the period to fill this bag. The content 
in a vacuum cleaner bag which has been used for a period of time will give an integrated 
measure of the PFC concentrations. The approach with researcher collected dust will only 
reflect the concentrations in the dust collected at a specific point of time. A third 
approach commonly applied involves sampling of a standardised floor area. Harrard et al. 
(2010) pinpointed that in general, a systematic procedure for sampling performed by a 
research team is favourable, and that dust collected from elevated surfaces may reflect the 
exposure of adult better than dust collected from the floor.  
 The predominant PFCs in the indoor air were the FTOHs, with highest 
median concentrations of 8:2 FTOH (5173 pg/m3), 10:2 FTOH (2822 pg/m3) and 6:2 
FTOH (933 pg/m3). MeFOSE and EtFOSE were the dominating FOSA/FOSEs with 
median values of 265 and 78 pg/m3. FTOHs are usually found in higher concentrations 
than FOSA/FOSEs in consumer products produced in recent years (Dorte Herzke, 
personal communication), thus our findings are reasonable. This is also supported by a 
recent study, where higher concentrations of FTOHs than FOSA/FOSEs were seen in 
most samples of indoor air collected in various shops selling products potentially 
containing PFCs (Langer et al. 2010). The concentrations of FTOHs observed in the 
BROFLEX study are similar to what has previously been found (Barber et al. 2007;Huber 
et al. accepted for publication;Shoeib et al. 2008), while the concentrations of 
FOSA/FOSEs generally were lower than reported elsewhere (Barber et al. 2007;Shoeib et 
al. 2004;Shoeib et al. 2005).  
Associations within and between different groups of PFCs were studied in the 
samples of air and dust, and significant correlations were found within the group of 
PFSAs in dust as well as among FTOHs and FOSA/FOSEs in air. On the other hand, only 
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a few significant correlations were observed among the PFCAs. As summarised by 
D’Hollander et al. (2010a) significant relationships both among and between groups of 
PFCs have been observed in other studies which has been interpreted as an indicator for a 
common source. The reason for the lack of associations among most PFCAs in our study 
is not known. 
FTOHs are likely to degrade to PFCAs in the atmosphere, thus being precursors of 
PFCAs (Ellis et al. 2004). Further, biotransformation of EtFOSA to PFOS has been 
reported (Tomy et al. 2004) and it has been anticipated that FOSA/FOSEs may also be 
transformed to PFSAs in the atmosphere. We found significant correlations between 
FOSA/FOSEs and PFSAs, while this was not seen for FTOHs and PFOA. This may 
indicate that, FOSA/FOSEs contribute to a larger extent to the indoor pollution with 
PFSAs than do FTOHs to PFOA pollution. A lack of correlation between FTOHs and 
PFOA does not mean that FTOHs are not degraded to PFOA, but other sources of PFOA 
are probably more pronounced. The distribution patterns of neutral PFCs in the indoor air 
samples were similar, in contrast to the large differences among samples of house dust. 
The reason for this remains to be clarified.  
The PFC concentrations found in indoor air and house dust are likely influenced 
by several factors. In a study by Langer et al. (2010) on PFCs in indoor air from shops 
selling products potentially containing PFCs, large differences in distribution patterns 
were observed among the samples. These variations are probably due to differences in the 
content of PFCs in the products. To identify determinants of PFC concentrations in 
samples of indoor air and house dust in the BROFLEX study, the measured PFC 
concentrations were combined with information from the questionnaires using bivariate 
and multiple regression analyses. The age of the residence was found to significantly 
influence the concentrations of several PFCs in dust and air. Decreasing PFC 
concentrations were observed with increasing age of the residence. This might be related 
to differences in the construction of the buildings, the age and types of the building 
materials, but could also be related to differences in the residents’ use of PFC-containing 
products. Also in a study from Canada, old houses had lower concentrations of PFHxS, 
PFOS and PFOA in house dust compared to new ones (Kubwabo et al. 2005). A 
suggested explanation for this was that old houses tended to have less carpeting than new 
ones. Carpets were also identified as a possible source of several PFCAs and PFSAs in a 
second study from Canada (Gewurtz et al. 2009). None of the houses in the BROFLEX 
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study had wall to wall carpets, however we explored possible associations between 
having a rug in the living room and the concentrations of PFCs in dust or air. With the 
exception of PFHxA, for which there was no association with the age of the residence, no 
significant associations were seen. Thus, the reason for lower concentrations of several 
PFCs observed in old houses compared to new ones in the BROFLEX study, remains to 
be clarified. In addition to the influence of the age of the residence on the PFC 
concentrations, significant relationships were observed for some other factors in the 
bivariate analyses, but only for one or two PFCs each. Due to the low number of samples 
analysed in this study, interpretations must be made with care. Associations seen only for 
a couple of PFCs can of course be due to different sources or specific physical-chemical 
properties for these compounds, but could also indicate that the relationships seen are 
accidental. Thus, no conclusions can be made based on those observations, and there is a 
need for further research to better understand the connection between use of various PFC 
containing products and concentrations in the indoor environment. 
Intake estimates 
Intakes of PFOS and PFOA from ingestion of house dust and inhalation of indoor 
air were estimated on an individual basis for the BROFLEX study group. Intakes were 
estimated according to three scenarios (see paragraph 3.8), due to high uncertainty in dust 
ingestion rates and biotransformation factors. The intakes for PFOS and PFOA from 
ingestion of house dust and inhalation of indoor air are illustrated in Figure 10 and 11, 
respectively and the median intakes were in the range 0.0004 to 0.077 ng/kg bw/day. For 
PFOS, intakes from dust were higher than for indoor air in scenario S1, while the 
opposite was seen for scenario S2 and S3 (Figure 10). For all three scenarios, higher 
proportions of the PFOA intakes from dust than indoor air were observed (Figure 11). In 
a recent study by Goosey and Harrad (2011), the median PFOS and PFOA intakes from 
dust ingestion (20 mg dust/day) were 0.05 and 0.06 ng/kg bw/day, respectively. This is 
higher than found for scenario S1 in our study, even though we assumed a higher dust 
ingestion rate (50 vs 20 mg/day). 
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Figure 10. Boxplot of individual intakes for PFOS from ingestion of house dust and inhalation of 
indoor air according to three different scenarios (S1, S2 and S3) 
 
 
 
 
 
 
 
 
 
Figure 11. Boxplot of individual intakes for PFOA from ingestion of house dust and inhalation of 
indoor air according to three different scenarios (S1, S2 and S3) 
 
ng
/k
g 
bw
/d
ay
 
ng
/k
g 
bw
/d
ay
 
 47
A Swedish study reported median intakes of both PFOS and PFOA from dust 
ingestion to be 0.3 ng/day, which corresponds to 0.004 ng/kg bw/day when assuming a 
body weight of 70 kg (Björklund et al. 2009). This is in the same range as found for 
scenario S1 in our study, but the Swedish study was based on a dust ingestion rate of only 
4.1 mg/day.  
These results illustrate that there are not only variations in PFC concentrations 
observed among studies, but the results are also influenced by the dust ingestion rates and 
biotransformation factors applied. Hence there is a need for better characterisation of 
these factors, and preferably a harmonisation of use of those, to be able to draw firm 
conclusions regarding differences among studies.  
4.3.3 Total exposure 
Exposure to PFCs can occur through several pathways as illustrated in Figure 2. 
The total exposure to PFOS and PFOA for the BROFLEX study group was assessed by 
including consumption of food and drinking water, inhalation of PFC-precursors in 
indoor air and ingestion of house dust. 
The median total intake of PFOS was estimated to be between 0.62 and 0.70 ng/kg 
bw/day depending on the dust ingestion rates and biotransformation factors applied (see 
Figure 12). Correspondingly, the median intakes of PFOA were in the range 0.26-0.33 
ng/kg bw/day (see Figure 13). This is in the same range as has been modelled for PFOS 
and PFOA in studies on populations exposed to background contamination levels 
(Egeghy and Lorber 2010;Fromme et al. 2009;Vestergren and Cousins 2009).  
Consumption of food was the dominating source of exposure for PFOS in all three 
scenarios (based on the median values), representing 88 to 99% of the total exposure for 
the individual women. Correspondingly, food consumption counted for 67 to 84% of the 
total PFOA exposure. Based on the assumptions in scenario S1, drinking water 
represented 0.68%, dust 0.41% and indoor air 0.10% of the median total intakes of PFOS. 
Drinking water represented 11%, dust 5.2% and indoor air 0.13% of the total intakes for 
PFOA in scenario S1.  
Comparison with other studies is challenging as different sources of exposure 
have been assessed. Further, the exposure parameters used, such as dust ingestion rates, 
varies between studies. However, food has also been identified as the major exposure 
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source of PFOS and PFOA in other adult general populations (Egeghy and Lorber 
2010;Fromme et al. 2009;Trudel et al. 2008;Vestergren and Cousins 2009). 
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Figure 12. Total intakes of PFOS estimated for the BROFLEX study group  
In a typical exposure scenario the median PFOS intakes from dust and drinking 
water represented only 6 and 22% of the total exposure for US adults, respectively 
(Egeghy and Lorber 2010). For PFOA, ingestion of dust and consumption of drinking 
water were also estimated to be minor exposure sources in background exposed 
populations reported by Vestergren and Cousins (2009).  
Food is known to be the major source of exposure for POPs like dioxins and PCBs 
(Liem et al. 2000). The high positive correlations between PFCs and PCBs seen in serum 
from the NFG study, supports that food also is a major source of exposure for PFCs. 
However, when assessing the relative contribution of different exposure pathways on an 
individual basis, large variations were observed. This is illustrated in Figure 14 where the 
relative contribution of intakes from food, drinking water, house dust and indoor air 
(scenario 1) are shown for two women in the BROFLEX study group. The total intakes of 
PFOS were 0.27 and 0.30 ng/kg bw/day for Woman 1 and 2, respectively. The 
corresponding intakes of PFOA were 0.15 and 0.16 ng/kg bw/day, i.e. very similar. 
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 Figure 13. Total intakes of PFOA estimated for the BROFLEX study group 
The relative importance of the PFOS exposure from dust and indoor air was quite 
high for some of the women (e.g. Woman 2), but for the majority of women more than 
80% of the total exposure originated from food consumption (e.g. Woman 1). For PFOA 
the influence of the indoor exposure was in general higher than for PFOS. Dust and 
indoor air represented more than 40% of the PFOA exposure for one forth of the women 
in the scenario comprising high dust ingestion.  
No other studies have so far assessed the PFC exposure from multiple sources on 
an individual basis. However the large variations observed among the individuals in this 
study (e.g. Woman 1 and 2 in Figure 14) underline the importance of performing such 
studies. Finding both PFC concentrations in dust and consumption of certain food types 
as predictors of serum PFC concentrations in the BROFLEX study group, also supports 
the large variations among individuals with respect to the relative contribution of 
different exposure pathways.  
Benskin et al. (2009) hypothesized that isomer specific biotransformation rates of 
PFOS-precursors may explain the common observation of enrichment of the branched 
PFOS isomer profiles in humans. In the BROFLEX study group, we found significant 
associations between the proportion of branched PFOS isomers in serum and the relative 
contribution of the total PFOS intake from inhalation of precursors in indoor air (Scenario 
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1; R=0.33; p=0.038). Thus, one might speculate that the abundance of branched PFOS 
isomers in human serum is related to intake of PFOS precursors. This remains to be 
clarified. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. Relative contribution of intakes from food, drinking water, dust and indoor air for 
PFOS and PFOA for two of the women in the BROFLEX study group 
4.3.4 Exposure of infants 
The exposure of infants through breast-feeding was assessed in the depuration rate 
study and the BROFLEX study. Intakes of 61 ng/day for PFOA and 112 ng/day for PFOS 
were estimated in the depuration rate study using the median concentrations of the first 
sample donated by each mother. When assuming a body weight of 4 kg, this corresponds 
to 15 and 28 ng/kg bw/day. The median intakes estimated for infants in the BROFLEX 
study were 4.1 and 8.7 ng/kg bw/day for PFOA and PFOS, respectively. This is about a 
fourth to one third of the intakes found in the depuration rate study. Several of the 
mothers in the BROFLEX study collected breast milk after some months of breast-
feeding. Thus, it is more appropriate to compare the BROFLEX intakes with intakes for 
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the depuration rate study based on the median values of all 70 samples collected during 
the lactation period. These intakes were similar.  
Intakes of PFCs through breast-feeding have been calculated in several other 
studies. For PFOS, mean intakes in the range 5.7-28.7 ng/kg bw/day has been reported 
(Kim et al. 2011;Tao et al. 2008a;Tao et al. 2008b;Völkel et al. 2008) while for PFOA, 
estimated intakes of 4.7 ng/kg bw/day in a Korean study (Kim et al. 2011) and 9.6 ng/kg 
bw/day in a study including samples from Japan were reported (Tao et al. 2008a). Thus, 
the intakes of PFOS and PFOA through breast-feeding reported in this thesis are 
comparable to what has been reported elsewhere. 
In the BROFLEX study, we assessed the exposure of PFOS and PFOA from 
multiple exposure pathways on an individual basis for infants at six months of age. We 
included intakes from consumption of breast milk, ingestion of dust and inhalation of 
indoor air. The median total intakes ranged from 8.7 to 9.1 ng/kg bw/day for PFOS and 
4.3 to 4.9 ng/kg bw/day for PFOA, depending on the dust ingestion rates and 
biotransformation factors used. Based on the median values, breast milk represented more 
than 94 and 83% of the exposure to PFOS and PFOA, respectively. So far no other 
studies have compared exposure pathways for infants based on individual measurements 
of PFC concentrations in breast milk, house dust and indoor air. However, Fromme et al. 
(2010) found significant associations between concentrations of PFOS in breast milk and 
infants blood at the age of six months in a German study, indicating that breast milk is a 
major source of exposure for infants up to six months. Egeghy and Lorber (2010) 
estimated route specific PFOS intakes for 2-year old children, finding that food, ingestion 
of dust and drinking water represented 42, 36 and 20% of the total intake. Further, in a 
study by Trudel et al. (2008) more than half of the PFOS exposure for infants and 
toddlers in a high exposure scenario originated from contact with PFC containing 
consumer products. Thus, breast milk is the dominating source of PFCs exposure for 
exclusively or predominantly breast-fed infants, while the importance of the indoor 
environment increases after weaning.  
4.4 Comparison of external and internal doses  
Comparisons between external and internal doses of PFCs were performed in 
Paper 4 and 7. 
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4.4.1 Associations between estimated intakes and concentrations of PFCs 
in blood 
For the NFG study significant associations between estimated total dietary intakes 
of PFOS, PFOA and PFUnDA, and measured serum concentrations of the corresponding 
compounds were found in both bivariate and MLR models. Bivariate associations for 
PFOS are illustrated in Figure 15.  
In the BROFLEX study no significant associations were found between total 
intakes of PFOS and PFOA (scenario 1, 2 and 3) and the corresponding serum 
concentrations. However, when dividing the intakes by route of exposure a significant 
association between intakes from dust ingestion and the concentrations of PFOA 
measured in serum was seen. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15. Relationship between estimated daily dietary intakes of PFOS divided in quartiles and 
the corresponding serum concentrations (mean and 95% CI), in the NFG-study  
A similar tendency was found for PFOS, but the relationship was not statistically 
significant. No significant correlations to dietary intakes were observed. This could be 
due to the limited number of women included in the study, but could also be caused by 
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little variation in dietary habits, less detailed FFQs, as well as insufficient information on 
PFCs in food. Another plausible explanation could be that the predominance of PFC 
intakes through food results in a "baseline" serum concentration, while the concentration 
above this "baseline" might be driven by the wide variation in dust intakes. Hence an 
association with dust is more likely to be found than with food. Neither were there 
relationships between intake of PFOS and PFOA from precursors in air and serum 
concentrations. This might be due to an actual low relative contribution of precursors in 
indoor air to the total intakes, but could also be related to variations in biotransformations 
among individuals.  
Fromme et al. (2007) examined relationships between concentrations of PFCs 
measured in serum and intakes calculated using duplicate diet samples collected over 
seven consecutive days. Kärrman et al. (2009) calculated intakes using concentrations 
determined in a one-day composite sample and compared with concentrations of PFOS 
and PFOA determined in serum. None of these studies found any significant relationships 
between dietary intakes and serum concentrations. However as pinpointed previously, for 
compounds with long half-lives such as most PFCs, the serum concentrations are 
accumulated from exposure during several years. Hence, the estimation of dietary intake 
using FFQs covering a longer time period, could have facilitated the finding of significant 
associations between diet and measured serum concentrations in the NFG study. 
4.4.2 Comparing external and internal doses using PK modelling 
In the BROFLEX study, the measured PFOS and PFOA concentrations in serum 
were compared with concentrations calculated from the total intakes using a PK model. 
The measured and calculated serum concentrations were found to be in the same range, 
indicating that the estimated intakes are reasonable. Similar results were seen in a 
German study, where a good agreement between intakes calculated using duplicate diet 
information and back-calculation from serum concentrations was observed (Fromme et al. 
2007). PK modelling was also used to compare intakes modelled for the US population 
with intakes back-calculated from serum concentrations in the National Health and 
Nutrition Examination Survey (NHANES) 2003/2004 study, and similar central 
tendencies were observed (Egeghy and Lorber 2010). However, the intake data and the 
serum data in this study did not originate from the same individuals. Equivalent findings 
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were also reported from two other modelling studies (Trudel et al. 2008;Vestergren and 
Cousins 2009).  
Despite the uncertainties associated with PK modelling, the results of our as well 
as other studies indicate that it can be a valuable tool in exposure assessment. 
4.5 Tolerable daily intakes 
The Scientific Panel on Contaminants in the Food Chain within the European 
Food Safety Authority (EFSA) has established tolerable daily intakes (TDI) for PFOS and 
PFOA of 150 ng/kg bw/day and 1500 ng/kg bw/day, respectively (EFSA 2008). In the 
NFG study, the maximum daily dietary intakes of PFOS and PFOA were 11 and 2.4 
ng/kg bw/day, respectively. None of the women in the BROFLEX study had estimated 
total intakes above this. Thus, all adults included in this project had estimated intakes 
more than 14 (PFOS) and 625 (PFOA) times below the TDIs. One has to keep in mind 
that the intake calculations within this thesis were based on a limited number of samples, 
and thus do not necessarily reflect the whole range of intakes for the Norwegian 
population. For instance, it is expected that the actual intakes for high consumers of fish 
from coastal fishing grounds could be higher, and the margin to the TDIs would 
necessarily become lower. 
The median total daily intakes of PFOS and PFOA per kg body weight for infants 
were 13-16 times higher than the corresponding estimates for adults. Thus, the maximum 
estimated intakes of PFOS and PFOA for infants 6 months of age (scenario 3) were only 
about 5 (PFOS) and 18 (PFOA) times below the TDIs. However, it has to be taken into 
account that TDIs are established for lifelong exposure and can not be applied to the 
relatively short period of breast-feeding.  
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4.6 Methodological strengths and limitations 
The major strength of this work is the assessment of exposure to perfluorinated 
compounds from various angels. Due to practical reasons some of the studies were 
limited in size. However results from the different investigations all supported each other, 
increasing the strength of the individual studies. A wide range of PFCs was determined in 
the studies, being favourable because of the change in use of PFCs as a consequence of 
the phase-out and regulations of PFOS and PFOA. Below follows an overview of 
strenghts and limitations of the individual studies. 
Table 3. Strengths (+) and limitations (-) in the studies included in this thesis 
 Strengths/limitations Consequences 
 Time trend study  
+ Frequent sampling (almost every year) 
during 30 years 
Advantageous for observing changes in 
concentrations over time 
- Only pooled samples were analysed No information on variation between 
individuals could be obtained 
- This was a cross-sectional study  It was not possible to examine changes of PFC 
concentrations in pools of the same individuals 
at different points of time 
- For the serum pools from 1976, 1987 
and 1998 information on each individual 
donor’s age was not available 
This complicates the assessment of the effect of 
age on PFC concentrations in serum 
- No information on diet etc.  was 
available for the subjects  
Could have an influence on the associations 
between age/gender and concentrations of PFCs 
in serum 
 Concentrations in Norwegian food  
+ Low LOQs We were able to detect low concentrations of 
several PFCs in the samples. This was 
advantageous to avoid overestimation of dietary 
intakes due to high LOQs 
+ PFCs were determined in a broad range 
of food types  
This is advantageous for calculating intakes 
+ Consumption data from the NORKOST 
survey were used  
The consumption data is representative for the 
Norwegian adult population  
- The NORKOST survey was carried out 
in 1997  
The consumption patterns in Norway might 
have changed to some extent since then 
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 Strengths/limitations Consequences 
- Only one sample of each kind was 
prepared and analysed (with the 
exception of drinking water)  
No information on variation within a type of 
food or beverage could be obtained. This adds 
uncertainty to the intakes estimated 
- Only unprocessed food was analysed in 
this study  
The measured concentrations do not necessary 
reflect the concentration in the food actually 
consumed 
 NFG study*  
+ A comprehensive FFQ covering the 
consumption over the last 12 months for 
the whole diet was used 
Favourable when assessing relationships 
between diet and measured serum 
concentrations for compounds with long half-
lives such as PFCs 
+ The FFQ has been validated and found 
satisfactory in a pregnancy sub-cohort 
Limits the uncertainty in the consumption data 
+ The study group comprised participants 
in a wide age-span, both men and 
women from both inland and costal 
municipalities throughout Norway 
which had a wide range of consumption, 
particularly of fish and shellfish 
This is favourable when exploring relationships 
between diet and serum concentrations 
+ The mean consume of fish and shellfish 
was comparable to the NORKOST 
survey which is representative to the 
general adult population  
The results might be applicable to the general 
adult Norwegian population 
- The information on PFC concentrations 
in food from Norway is limited 
This adds uncertainty to the estimated intakes  
 Depuration rate study  
+ Frequent sampling and large number of 
breast milk samples obtained from each 
mother 
This is favourable when exploring depuration 
rates 
- The number of mothers included was 
restricted 
This has negative influence on the statistical 
power 
 BROFLEX study**  
+ Unique design  Ability to assess multiple human exposure 
pathways of PFCs on an individual basis and 
compare with biomonitoring data 
+ Comprehensive information was 
obtained from each individual 
Allowed exploration of various factors in MLR 
analyses 
- The participants were not randomly 
selected 
The samples are not necessarily representative 
for the Norwegian general population 
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 Strengths/limitations Consequences 
- The number of investigated households 
was limited to 41 for practical reasons 
This limits the statistical power 
- The FFQ was not as extensive as in the 
NFG study. 
This could result in higher uncertainty in the 
calculations of dietary intakes. However, the 
intakes estimated were similar to what was 
observed in a study on pregnant women, where 
the FFQ used was equal to that in the NFG 
study (Anne Lise Brantsæter, personal 
communication) 
- The study includes sampling of indoor 
air and house dust only in the residence 
(not other microenvironments such as 
the work place) and only once 
Variations in PFC concentrations over time and 
among microenvironments could not be 
considered 
- Due to the method used for collection of 
PFCs in air it was not possible to 
distinguish between PFC concentrations 
in gas and particulate phase.  
The intakes of FOSA/FOSEs and FTOHs from 
air comprised the sum of the amount in gas 
phase and particulate phase. However, 
according to Barber et al. (2007) only a minor 
amount of neutral PFCs was found on particles 
in air in indoor environments 
- The exposure through inhalation of low 
contaminated outdoor air has been 
neglected 
Could lead to a slight over-estimation of intake 
through inhalation  
- Exposure to PFCs through dermal 
absorption has not been included in this 
project.  
This could result in an under-estimation of the 
total intakes. However, the dermal uptake is 
suggested to be low 
- Biotransformation of precursors have 
not been considered for exposure from 
food 
This could result in an under-estimation of the 
total intakes.  
- Biotransformation of precursors have 
not been considered for exposure from 
dust 
This could result in an under-estimation of the 
total intakes. However, neutral PFCs have high 
vapour pressures and are found predominately 
in the gas phase, and the concentrations of 
FOSAs, FOSEs and FTOHs in dust are thus 
thought to be low 
- Only indirect exposure through 
precursors was assessed for indoor air  
This could result in an under-estimation of the 
total intakes. However, the vapour pressures of 
PFCAs and PFSAs in dissociated form are 
expected to be low, thus these PFCs are mainly 
bound to particles 
* Strengths and limitations for the NFG study in general have also been thoroughly discussed by Kvalem (2010).  
** Uncertainties associated with PK modelling has been thoroughly discussed elsewhere (Egeghy and Lorber 
2010;Trudel et al. 2008;Vestergren and Cousins 2009)  
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5. CONCLUDING REMARKS AND 
FUTURE PERSPECTIVES 
In serum samples from the Norwegian population collected almost annually 
between 1976 and 2007, we explored the changes in concentrations of a range of PFCs. 
The serum concentrations of most PFCs increased throughout the 1990s, which collate 
with increasing use of PFCs during this period. Declining concentrations of some PFCs 
(e.g. PFOS and PFOA) were seen from around year 2000 in line with the phase-out of 
these compounds. However, in the same period no reductions were observed for the 
longer chained PFCAs (i.e. PFNA, PFDA and PFUnDA). This could be due to longer 
half-lives or different use of these compounds. After the phase-out of PFOS and PFOA 
the production has shifted towards PFCs with shorter chain lengths. The phase-out out of 
high production volume chemicals may also lead to increased production of chemicals 
that might degrade to PFCAs and PFSAs. This underlines the importance of continuous 
human biomonitoring.  
The levels of PFCs in Norwegian serum and breast milk studied in this thesis were 
compareable to those found in other studies from industrialised countries, indicating a 
similar degree of exposure. However, the concentrations in food, house dust and indoor 
air were generally lower. Comparison of studies on external exposure is challenging as 
different sampling strategies and analytical methods may have large impact on the results. 
To be able to reveal temporal and geographical variations, there is a need for 
harmonisation of sampling and analyses in the future. 
When this project was started the knowledge on PFCs levels in breast milk and the 
impact of lactation on maternal body burdens was very limited. We found strong 
relationships between concentrations of PFOS in paired samples of serum and breast 
milk, and the same was seen for PFOA. Further, during the course of lactation declining 
concentrations of PFOS and PFOA were observed in breast milk, and previous breast-
feeding was identified as an important factor for maternal serum PFC concentrations. 
These findings underline the necessity for obtaining information on breast-feeding in 
future studies on PFCs in women. Breast milk was found to be the major source of 
exposure to PFCs for exclusively or predominantly breast-fed infants, and the total daily 
intakes per kg body weight were 13-16 times higher than the corresponding intakes for 
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adults. The highest individual intakes were relatively close to the current TDIs for life 
long exposure. 
Several factors influence the body burdens of PFCs, which reflects an integrated 
exposure over time comprising various sources. Major determinants of PFC 
concentrations in serum identified in this thesis were breast-feeding status, age, 
consumption of fish, shellfish and meat as well as concentrations of PFCs in house dust. 
Knowledge on and inclusion of such determinants are crucial when exploring associations 
between serum concentrations and e.g. health outcomes. 
The knowledge on factors influencing the PFC levels in indoor environments is 
limited. An association between percentage of carpeting and concentrations of PFCs in 
the indoor environment has been reported, and in the BROFLEX study we found that 
older residences tend to have lower PFC levels in dust and air than new ones. The reasons 
for that remain to be clarified. More information on the variation of PFC concentrations 
within and between types of food and beverages is also required. 
Total intakes through consumption of food and drinking water, ingestion of house 
dust and inhalation of indoor air were found to be comparable or lower than reported in 
other studies. This may partly be explained by the lower levels observed in our samples. 
However, there is a need for further knowledge on dust ingestion rates and 
biotransformation factors of precursor compounds. This has also been highlighted by 
Harrad et al (2010). Despite the underlying uncertainties, PK modelling indicated that the 
intakes estimated in the BROFLEX study are reasonable.  
Food was generally the major source of exposure, especially fish and shellfish, and 
for the first time, strong relationships between measured concentrations of PFCs in serum 
and calculated dietary PFC intakes were reported. Nevertheless, in the BROFLEX study 
large individual variations were observed for the relative contributions of the various 
exposure pathways to the total intake of PFCs. This underlines the importance of 
performing studies considering multiple exposure sources on an individual basis. Further, 
the high influence of indoor exposure for several individuals as well as finding ingestion 
of house dust as a determinant of serum concentrations, highlights the importance of 
including indoor environment when characterising human exposure to PFCs. More efforts 
are needed to investigate other indoor environments, assess more homes and examine the 
variability within and between rooms. The contribution of various sources to PFC 
exposure might also differ between countries and regions. 
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Large variations between individuals were observed in the proportion of branched 
PFOS isomers in serum and breast milk. Higher proportions of branched isomers were 
observed for the women with the highest relative contribution to total PFOS intake from 
inhalation of precursors in indoor air. This agrees with the hypothesis that the abundance 
of branched PFOS isomers in human serum is related to the intake of PFOS precursors. 
Using the applied analytical method it was possible to distinguish between branched and 
linear PFOS, but with this method the individual branched isomers could not be 
quantified. Information on the relative contribution of the individual branched PFOS 
isomers in serum would be valuable to shed light on the impact of precursor compounds. 
More knowledge on biotransformation rates of precursors are also needed to understand 
their contribution to body burdens of ionic PFCs. 
None of the participants in this study exceeded the TDIs established by The 
Scientific Panel on Contaminants in the Food Chain within EFSA. However in general, 
for instance for high consumers of fish from costal fishing grounds, the margins to the 
TDIs could be low. Further, for six months old infants, the maximum estimated intakes 
were relatively close to the current TDIs for lifelong exposure. Thus, given the high 
uncertainties both related to the TDIs and the intakes, all available strategies should be 
utilised to minimise human exposure to PFCs to limit the potential risk of adverse health 
effects. 
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Appendix 
 
 
 
  
 
 
Blir vi utsatt for miljøgifter fra innemiljøet? 
 
 
Spørreskjema for deltakere 
 
 Konfidensielt 
Navn  
 
Fødselsdato (dd/mm/åååå) 
Adresse  
 
 
Dato  
 
Hvor mange personer bor i boligen?          
 
Antall voksne…………………         Antall barn …………..  Barnas alder……………………… 
Hvilken type bolig bor du i? (sett x ved det som passer) 
 
Enebolig/rekkehus …………..        Leilighet ……………… eventuelt etasje nr……………. 
Hvor lenge har du bodd i boligen?  
 
………………….. år 
Når ble boligen bygget?  
 
……………………..(ca årstall) 
Hvor stor er boligen?  
 
Totalt ………….kvm        Stue……………kvm               Ditt soverom…………..kvm 
Er det ventilasjonsanlegg i boligen?     
 
 Ja       Nei 
Hvordan varmes boligen opp?  (sett x ved det som passer) 
 
Sentralfyr         Elektrisk         Vedfyring           Olje/parafin  
Finnes sterkt trafikkert(e) vei(er) mindre enn 500 m fra boligen?   
(alltid minst en bil å se på veien hele dagen) 
 
 Ja       Nei       Hvis ja, omtrent hvor langt unna er veien (i meter) ………………… 
Finnes industriområde(r) mindre enn 500 m fra boligen? 
 
 Ja       Nei       Hvis ja, hvilken type industri?........................................................... 
Luftes det daglig?  
  
I stua:      Ja       Nei                På soverommet:    Ja       Nei   
Røykes det i hjemmet?  
 
 Ja       Nei 
 
Hvis ja, i hvilke rom? (sett x ved det som passer) 
 
Stue         Kjøkken          Soverom          Bad             Gang              Arbeidsrom  
 
Hvis ja, hvor mange sigaretter røykes i hjemmet per dag? ……………. 
Røyker du?  (sigaretter, rullings) 
 
Aldri røykt   Sluttet    Av og til     1-10 daglig    10-20 daglig      > 20 
          
                                                                              
Omtrent hvor mange timer per dag oppholder du deg i hvert av disse rommene?  
(inkludert når du sover) 
 
Stue ………   Kjøkken ………   Soverom………   Arbeidsrom ……… 
Har du/dere husdyr i leiligheten? 
 
 Ja         Nei 
 
Hvis ja, hvilke(t) husdyr? ……………………………………………………………………… 
 Har du følgende materialer i stuen? (spesifiser type materiale f.eks ull, syntetisk, bomull, vinyl 
og annet, og alder på materialene) 
 
 Ja / Nei Materiale Alder (år) 
   Under 1 år 1-5 år Mer enn 5 år 
Vegg-til-vegg teppe  Ja         Nei     
Gulvteppe  Ja         Nei     
Gulvbelegg  Ja         Nei     
Polstret stol                Ja         Nei     
Polstret sofa  Ja         Nei     
 
Har du følgende materialer i ditt soverom? (spesifiser type materiale f.eks ull, syntetisk, 
bomull, vinyl og annet, og alder på materialene) 
 
 Ja / Nei Materiale Alder (år) 
   Under 1 år 1-5 år Mer enn 5 år 
Vegg-til-vegg teppe  Ja         Nei     
Gulvteppe  Ja         Nei     
Gulvbelegg  Ja         Nei     
Madrass  Ja         Nei     
Overmadrass  Ja         Nei     
Teppe/dyne                Ja         Nei     
Pute      Ja         Nei     
  
 
 Har du/dere en eller flere av følgende elektriske apparater:  
 
 Ja Nei Antall i husholdningen Alder på apparatet/apparatene 
    
Under 
1 år 1-5 år 
Mer enn 
5 år 
TV        
TV med flatskjerm        
Video/DVD        
TVspillkonsoll       
CDspiller       
Stasjonær datamaskin       
Bærbar datamaskin       
Dataskjerm       
Flatskjerm til datamaskin       
Skriver/kopimaskin/telefax       
Radio/forsterker/høytalere       
Telefon og mobiltelefon       
Mikrobølgeovn       
Kaffetrakter       
Vannkoker       
Food processor/mikser       
Komfyr       
Kjøleskap       
Fryser       
Oppvaskmaskin       
Vaskemaskin       
Tørketrommel       
Gulvstøvsuger       
Sentralstøvsuger       
Annet:        
 Hvor ofte og hvor lenge bruker du eller en av de andre i husholdningen følgende elektriske 
apparater:  (hvis du har flere av en kategori summerer du bruken av disse, eks: hvis TV står på 5 
dager i uka i 2 timer per dag, skriver du tallet 5 i kolonnen Ukentlig og 10 i kolonnen Timer i bruk) 
 
 Daglig Ukentlig Månedlig Timer i bruk 
TV      
TV med flatskjerm      
Video/DVD      
CDspiller     
TVspillkonsoll     
Stasjonær datamaskin     
Bærbar datamaskin     
Dataskjerm     
Flatskjerm til datamaskin     
Skriver/kopimaskin/telefax     
Radio/Forsterker     
Telefon og mobiltelefon     
Mikrobølgeovn     
Kaffetrakter     
Vannkoker     
Food processor/Mikser     
Komfyr     
Oppvaskmaskin     
Vaskemaskin     
Tørketrommel     
Gulvstøvsuger     
Sentralstøvsuger     
Annet:      
 Skaffer du/dere oftest nye eller brukte forbruksvarer?  (sett kryss) 
 
 Nesten alltid nytt Oftest nytt Oftest brukt Alltid 
brukt 
Bil     
Sofa/møbler     
Barneklær     
Egne klær     
TV/PC/stereoanlegg osv.     
Hvitevarer     
Hva slags type materiale er det på de klærne du bruker som er i direkte kontakt med 
huden? (sett x ved kategorien som passer best. 1 betyr at klærne kun er laget av naturlige 
materialer, 3 betyr at halvparten av innholdet er syntetisk og halvparten er naturlig, mens 5 betyr at 
klærne kun er laget av syntetiske materialer) 
1 = 100% naturlig materiale      - - - - - - -     5 = 100% syntetisk materiale 
     
1 2 3 4 5 
Undertøy      
Bukse/skjørt      
Bluse/kjole      
Sokker/strømper      
 
Hvor er TV’en(e) plassert? (du kan sette flere kryss) 
Stue       Kjellerstue    Soverom Gang    Annet sted 
                                                                     ............................................ (spesifiser) 
Hvor er PC’en(e) plassert? (du kan sette flere kryss) 
 
Stue    Hjemmekontor     Soverom    Gang      Annet sted 
                                                                      ............................................ (spesifiser) 
Har dere klær av Gore-Tex® eller Gore-Tex® lignende materiale? 
 
  Ja         Nei   hvis ja, antall:……… 
 Har dere sko med Gore-Tex® eller Gore-Tex® lignende materiale? 
 
  Ja         Nei   Hvis ja, antall par:……… 
Benytter du/dere kjeler eller stekepanner med Teflon® eller lignende belegg i matlaging?  
 
  Ja         Nei 
 
Benytter du/dere kjøkkenredskaper med Teflon® eller lignende belegg i matlaging?   
 
  Ja         Nei 
Har du vanligvis et arbeid du utfører andre steder enn hjemme?     Ja         Nei                   
 
Hvor mange timer jobber du da per dag?              ……………………………..timer 
 
Hvor mange dager i uka jobber du?                       ……………………………..dager 
 
Hvilken andel av tiden jobber du med elektrisk utstyr (f.eks PC) ?   ………prosent 
Gi en kort beskrivelse av din jobb og materialer du jobber med: 
………………………………………………………………………………………………………… 
 
 ………………………………………………………………………………………………………… 
 
Eier/benytter du en bil?     Ja         Nei   
Hvis ja: 
Hvilket merke har den? ……………………… 
Hvilken årsmodell er den? ………………….. 
I gjennomsnitt per dag, hvor mange timer tilbringer du i denne bilen?  ……………timer 
Bruker du noen andre biler i jobb eller privat?      Ja         Nei  
Hvis ja: 
Hvilket merke har den? ……………………… 
Hvilken årsmodell er den? ………………….. 
I gjennomsnitt per dag, hvor mange timer tilbringer du i denne bilen?  ……………timer 
Eier/benytter du en campingvogn?     Ja         Nei   
Hvis ja: 
Hvilken årsmodell er den? …………………. 
I gjennomsnitt per år, hvor mange dager tilbringer du i denne campingvognen?  ……………dager 
Hvor ofte i gjennomsnitt blir ditt soverom og stuen støvsuget? 
 
Stuegulv          …………… (antall ganger) per ………......... uke/måned  (stryk det som ikke passer) 
 
Soveromsgulv …………… (antall ganger) per ………......... uke/måned  (stryk det som ikke passer) 
Når ble dette gjort forrige gang?.......................... 
Hvor ofte i gjennomsnitt blir ditt soverom og stuen vasket? 
 
Stuegulv          …………… (antall ganger) per ………......... uke/måned  (stryk det som ikke passer) 
 
Soveromsgulv …………… (antall ganger) per ………......... uke/måned  (stryk det som ikke passer)  
Når ble dette gjort forrige gang?.......................... 
Benytter du/dere poleringsmiddel for eksempel til polering av gulv, stuebord eller annet? 
 
  Ja         Nei 
Hvis ja, hva heter poleringsmiddelet? ……………………………………….. 
Har ett eller flere av følgende rom blitt renovert/pusset opp etter at blodprøven til prosjektet 
ble tatt?  
 
 Ja Nei Hvis ja, hva har blitt gjort? 
Stue      
Kjøkken     
Soverom     
Bad      
Gang     
Arbeidsrom    
Har du flyttet etter at blodprøven til prosjektet ble tatt?  
 
 Ja         Nei  
Har du/dere kjøpt noen nye møbler og/eller gulvtepper etter at blodprøven til prosjektet ble 
tatt? 
 
 Ja         Nei 
Hvis ja, spesifiser: …………………………………………………………………………. 
 Har du/dere kjøpt noen nye elektriske artikler etter at blodprøven til prosjektet ble tatt? 
 
Ja         Nei 
Hvis ja, spesifiser: …………………………………………………………………………. 
Hvilken utdannelse har du? 
 9 årig grunnskole  
 1-2 årig videregående  
 3 årig videregående      
 Distrikthøyskole/universitet inntil 4 år     
 Universitet/høyskole mer enn 4 år  
Har du født barn? 
 
 Ja         Nei 
    
Hvis JA: 
   
Ammet du? 
1. barn født………………:                Ja         Nei              Eventuelt hvor lenge: 
2. barn født………………:                Ja         Nei              Eventuelt hvor lenge: 
3. barn født………………:                Ja         Nei              Eventuelt hvor lenge: 
Hva veier du: 
 
Hvor høy er du: 
 
Er du født i Norge?             Ja         Nei 
Er din mor født i Norge?    Ja         Nei 
Er din far født i Norge?      Ja         Nei 
 
Hvis NEI: 
Hvilket land er du, din mor og far født i? 
Du:   ……………………………………………… 
Mor:  ……………………………………………... 
Far:   ……………………………………………... 
 
 Har du bodd i utlandet i mer enn 6 mnd? 
 Ja         Nei 
 
Hvis JA: 
Hvor har du bodd lengst? 
Norden     Europa      Afrika      Østen     Midtøsten     USA/Canada      Sør-Amerika       Oseania 
                                                                                                                   
KOSTHOLD 
Hvor mange ganger i livet omtrent har du spist: 
 
 Aldri 1-10 11-100 Mer enn 100 
Gjedde     
Fiskemølje     
Måsegg     
Lever eller nyre fra vilt     
Krabber     
KOSTHOLDET DITT DET SISTE ÅRET 
Viktig: Velg å svare på antall ganger per uke, måned, ELLER i året for hver matsort ettersom hva som  
passer best!  
 
 Sett x Sett antall i 
 Aldri Uken Måneden Året 
Pålegg og annet:     
Ost (påleggsporsjoner)     
Egg (utenom middag)     
Melk/yoghurt (antall glass)     
   Sett x Sett antall i 
 Aldri Uken Måneden Året 
Peanøtter      
Tran     
Leverpostei     
Makrell/laks som pålegg     
Krabbepålegg     
Tunfisk i boks     
Svolværpostei 
(og andre fiskeleverposteier) 
    
Middagsporsjon:     
Hvitt kjøtt (kylling, kalkun)     
Svinekjøtt     
Oksekjøtt     
Sau/lammekjøtt     
Bearbeidet kjøtt 
(deig, kaker, pølse) 
    
Egg 
(omelett, pannekaker m.m.) 
    
Lever/nyre fra elg/vilt     
Lever/nyre fra okse, sau og gris     
Makrell, laks, ørret og sild     
Torsk, sei, flyndre     
Kolje/hyse     
Kveite/hellefisk     
Gjedde og abbor     
Bearbeidet fisk 
(pinner/gratenger) 
    
   
  Sett x Sett antall i 
 Aldri Uken Måneden Året 
Lever fra torsk eller sei     
Skjell (Blåskjell/kamskjell)     
Reker     
Krabbe     
Middag uten kjøtt/fisk/egg 
(grøt, vegetar) 
    
FISK, KRABBE M.M. 
Hvis du spiser selvfisket/selvfangede produkter som fisk, krabbe o.s.v. (eller noen du 
kjenner fisker/fanger det for deg):     
Hva heter fjorden som sjømaten vanligvis kommer fra? 
Oppgi fjordens navn: 
 
Hva heter vannet som sjømaten vanligvis kommer fra? 
Oppgi vannets navn: 
 
Hvilken sjømat gjelder dette (krabbe, sei, ørret m.m.)? 
Oppgi navn: 
 
 
 
 
Takk for at du tok deg tid til å svare på spørreskjemaet! 
 
